Akkermansia muciniphila Muc is an anaerobe, Gram-negative, rod-shaped bacterium that was isolated from human intestinal tract .
Gram-negative rod-shaped anaerobe genome sequence 16S sequence Bacteria| @ref 20215 |
|
|
| Domain Bacteria |
| Phylum Verrucomicrobiota |
| Class Verrucomicrobiia |
| Order Verrucomicrobiales |
| Family Akkermansiaceae |
| Genus Akkermansia |
| Species Akkermansia muciniphila |
| Full scientific name Akkermansia muciniphila Derrien et al. 2004 |
| BacDive ID | Other strains from Akkermansia muciniphila (2) | Type strain |
|---|---|---|
| 131145 | A. muciniphila YL44, DSM 26127 | |
| 163900 | A. muciniphila JCM 30893 |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 16637 | PYG MEDIUM (MODIFIED) (DSMZ Medium 104) | Medium recipe at MediaDive | Name: PYG MEDIUM (modified) (DSMZ Medium 104) Composition: Yeast extract 10.0 g/l Peptone 5.0 g/l Trypticase peptone 5.0 g/l Beef extract 5.0 g/l Glucose 5.0 g/l L-Cysteine HCl x H2O 0.5 g/l NaHCO3 0.4 g/l NaCl 0.08 g/l K2HPO4 0.04 g/l KH2PO4 0.04 g/l MgSO4 x 7 H2O 0.02 g/l CaCl2 x 2 H2O 0.01 g/l Hemin 0.005 g/l Ethanol 0.0038 g/l Resazurin 0.001 g/l Tween 80 Vitamin K1 NaOH Distilled water | ||
| 16637 | SCHAEDLER BROTH (ROTH; 5772) (DSMZ Medium 1669) | Medium recipe at MediaDive | Name: SCHAEDLER BROTH (Roth; 5772) (DSMZ Medium 1669) Composition: Glucose 5.83 g/l Casein peptone 5.66 g/l Yeast extract 5.0 g/l Peptone mixture 5.0 g/l Tris 3.0 g/l NaCl 1.66 g/l Soy peptone 1.0 g/l K2HPO4 0.83 g/l L-Cysteine HCl x H2O 0.4 g/l Hemin 0.01 g/l Resazurin 0.001 g/l Distilled water | ||
| 40737 | MEDIUM 187 - for anaerobic bacteria | Distilled water make up to (1000.000 ml);Glucose (5.000 g);Yeast extract(20.000 g);Tryptone (30.000 g);Cysteine hydrochloride (0.500 g);Hemin solution - M00149(25.000 ml) | |||
| 121158 | CIP Medium 20 | Medium recipe at CIP | |||
| 121158 | CIP Medium 486 | Medium recipe at CIP | |||
| 121158 | CIP Medium 187 | Medium recipe at CIP |
| @ref | Spore formation | Confidence | |
|---|---|---|---|
| 125439 | 97.177 |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68380 | 29016 ChEBI | arginine | - | hydrolysis | from API rID32A |
| 68380 | 16024 ChEBI | D-mannose | - | fermentation | from API rID32A |
| 68380 | 17632 ChEBI | nitrate | - | reduction | from API rID32A |
| 121158 | 17632 ChEBI | nitrate | - | reduction | |
| 121158 | 16301 ChEBI | nitrite | - | reduction | |
| 68380 | 16634 ChEBI | raffinose | - | fermentation | from API rID32A |
| 68380 | 27897 ChEBI | tryptophan | - | energy source | from API rID32A |
| 68380 | 16199 ChEBI | urea | - | hydrolysis | from API rID32A |
| @ref | Chebi-ID | Metabolite | Indole test | |
|---|---|---|---|---|
| 68380 | 35581 ChEBI | indole | - | from API rID32A |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68382 | acid phosphatase | - | 3.1.3.2 | from API zym |
| 68380 | alanine arylamidase | - | 3.4.11.2 | from API rID32A |
| 68382 | alkaline phosphatase | - | 3.1.3.1 | from API zym |
| 68380 | alkaline phosphatase | - | 3.1.3.1 | from API rID32A |
| 68380 | alpha-arabinosidase | - | 3.2.1.55 | from API rID32A |
| 68382 | alpha-chymotrypsin | - | 3.4.21.1 | from API zym |
| 68382 | alpha-fucosidase | - | 3.2.1.51 | from API zym |
| 68380 | alpha-fucosidase | - | 3.2.1.51 | from API rID32A |
| 68382 | alpha-galactosidase | - | 3.2.1.22 | from API zym |
| 68382 | alpha-glucosidase | - | 3.2.1.20 | from API zym |
| 68380 | alpha-glucosidase | - | 3.2.1.20 | from API rID32A |
| 68382 | alpha-mannosidase | - | 3.2.1.24 | from API zym |
| 68380 | arginine dihydrolase | - | 3.5.3.6 | from API rID32A |
| 68382 | beta-galactosidase | + | 3.2.1.23 | from API zym |
| 68380 | beta-Galactosidase 6-phosphate | - | from API rID32A | |
| 68382 | beta-glucosidase | - | 3.2.1.21 | from API zym |
| 68380 | beta-glucosidase | - | 3.2.1.21 | from API rID32A |
| 68382 | beta-glucuronidase | - | 3.2.1.31 | from API zym |
| 68380 | beta-glucuronidase | - | 3.2.1.31 | from API rID32A |
| 121158 | catalase | - | 1.11.1.6 | |
| 68382 | cystine arylamidase | - | 3.4.11.3 | from API zym |
| 68382 | esterase (C 4) | - | from API zym | |
| 68382 | esterase lipase (C 8) | - | from API zym | |
| 68380 | glutamyl-glutamate arylamidase | - | from API rID32A | |
| 68380 | glycin arylamidase | - | from API rID32A | |
| 68380 | histidine arylamidase | - | from API rID32A | |
| 68382 | leucine arylamidase | - | 3.4.11.1 | from API zym |
| 68380 | leucine arylamidase | - | 3.4.11.1 | from API rID32A |
| 68380 | leucyl glycin arylamidase | - | 3.4.11.1 | from API rID32A |
| 68382 | lipase (C 14) | - | from API zym | |
| 68382 | N-acetyl-beta-glucosaminidase | + | 3.2.1.52 | from API zym |
| 68382 | naphthol-AS-BI-phosphohydrolase | - | from API zym | |
| 121158 | oxidase | - | ||
| 68380 | phenylalanine arylamidase | - | from API rID32A | |
| 68380 | proline-arylamidase | - | 3.4.11.5 | from API rID32A |
| 68380 | pyrrolidonyl arylamidase | - | 3.4.19.3 | from API rID32A |
| 68380 | serine arylamidase | - | from API rID32A | |
| 68382 | trypsin | - | 3.4.21.4 | from API zym |
| 68380 | tryptophan deaminase | - | 4.1.99.1 | from API rID32A |
| 68380 | tyrosine arylamidase | - | from API rID32A | |
| 121158 | urease | - | 3.5.1.5 | |
| 68380 | urease | - | 3.5.1.5 | from API rID32A |
| 68382 | valine arylamidase | - | from API zym |
| @ref | URE | ADH (Arg) | alpha GAL | beta GAL | beta-Galactosidase 6-phosphatebeta GP | alpha GLU | beta GLU | alpha ARA | beta GUR | beta-N-Acetyl-beta-glucosaminidasebeta NAG | MNE | RAF | GDC | alpha FUC | Reduction of nitrateNIT | IND | PAL | L-arginine arylamidaseArgA | ProA | LGA | Phenylalanine arylamidasePheA | Leucine arylamidaseLeuA | PyrA | Tyrosine arylamidaseTyrA | Alanine arylamidaseAlaA | Glycin arylamidaseGlyA | Histidine arylamidaseHisA | Glutamyl-glutamate arylamidaseGGA | Serine arylamidaseSerA | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16637 | - | - | + | + | - | - | - | - | - | + | - | - | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
| 16637 | - | - | + | + | - | - | - | - | - | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
| 16637 | - | - | - | +/- | - | - | - | - | - | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
| 16637 | - | - | + | + | - | - | - | - | - | + | - | - | + | - | - | - | - | + | - | - | - | - | - | - | - | - | - | - | - | |
| 16637 | - | - | + | + | - | - | - | - | - | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
| 16637 | - | - | + | + | - | - | - | - | - | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
| 16637 | - | - | +/- | + | - | - | - | - | - | + | - | - | + | - | - | - | - | +/- | - | - | - | - | - | - | - | - | - | - | - | |
| 16637 | - | - | + | + | - | - | - | - | - | +/- | - | - | + | - | - | - | - | +/- | - | - | - | - | - | - | - | - | - | - | - | |
| 16637 | - | - | + | + | - | - | - | - | - | + | - | - | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
| 16637 | - | - | + | + | - | - | - | - | - | + | - | - | + | - | - | - | - | + | - | - | - | - | - | - | - | - | - | - | - |
| Cat1 | Cat2 | Cat3 | |
|---|---|---|---|
| #Host | #Human | - | |
| #Host Body Product | #Gastrointestinal tract | #Feces (Stool) |
| @ref | Sample type | Host species | Sampling date | Country | Country ISO 3 Code | Continent | Isolation date | |
|---|---|---|---|---|---|---|---|---|
| 16637 | human intestinal tract (feces) | Homo sapiens | Netherlands | NLD | Europe | |||
| 63059 | Human feces | Homo sapiens | 2002-03-01 | Netherlands | NLD | Europe | ||
| 67770 | Human feces from a healthy adult volunteer | Homo sapiens | Netherlands | NLD | Europe | |||
| 121158 | Human, Feces | Homo sapiens | Netherlands | NLD | Europe | 2002 |
Global distribution of 16S sequence AY271254 (>99% sequence identity) for Akkermansia muciniphila subclade from Microbeatlas ![]()
| @ref | Description | Assembly level | INSDC accession | BV-BRC accession | IMG accession | NCBI tax ID | Score | |
|---|---|---|---|---|---|---|---|---|
| 124043 | ASM1750414v1 assembly for Akkermansia muciniphila ATCC BAA-835 | complete | 349741 | 99.8 | ||||
| 67770 | ASM2022v1 assembly for Akkermansia muciniphila ATCC BAA-835 | complete | 349741 | 99.66 | ||||
| 66792 | ASM800097v1 assembly for Akkermansia muciniphila DSM 22959 | complete | 239935 | 99.62 |
| @ref | Trait | Model | Prediction | Confidence in % | In training data |
|---|---|---|---|---|---|
| 125439 | gram_stain | BacteriaNetⓘ | negative | 89.14 | no |
| 125439 | oxygen_tolerance | BacteriaNetⓘ | facultative anaerobe | 93.84 | no |
| 125439 | motility | BacteriaNetⓘ | yes | 51.94 | no |
| 125439 | spore_formation | BacteriaNetⓘ | no | 97.18 | no |
| @ref | Trait | Model | Prediction | Confidence in % | In training data |
|---|---|---|---|---|---|
| 125438 | gram-positive | gram-positiveⓘ | no | 95.21 | no |
| 125438 | anaerobic | anaerobicⓘ | yes | 74.85 | yes |
| 125438 | aerobic | aerobicⓘ | no | 84.69 | no |
| 125438 | spore-forming | spore-formingⓘ | no | 88.13 | no |
| 125438 | thermophilic | thermophileⓘ | no | 93.00 | yes |
| 125438 | flagellated | motile2+ⓘ | no | 83.46 | no |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Utilization of Ningxiang pig milk oligosaccharides by Akkermansia muciniphila in vitro fermentation: enhancing neonatal piglet survival. | Zhang L, Wu Z, Kang M, Wang J, Tan B. | Front Microbiol | 10.3389/fmicb.2024.1430276 | 2024 | ||
| Strain-Specific Safety Evaluation of Akkermansia muciniphila Akk11: Comprehensive Genotypic, Phenotypic, and Toxicological Assessment. | Wang X, Fan Y, Dong Y, Zhang Y, Tan X, Gai Z, Sun Y, Fang S. | Food Sci Nutr | 10.1002/fsn3.71154 | 2025 | ||
| Incorporation of Bifidobacterium animalis subspecies lactis BB-12® and Akkermansia muciniphila in chocolate matrices | Vedor R, Machado D, Barbosa JC, Almeida D, Gomes AM. | Lebensm Wiss Technol | 2023 | |||
| Akkermansia muciniphila Encapsulated in Calcium-Alginate Hydrogelated Matrix: Viability and Stability over Aerobic Storage and Simulated Gastrointestinal Conditions. | Machado D, Fonseca M, Vedor R, Sousa S, Barbosa JC, Gomes AM. | Gels | 10.3390/gels9110869 | 2023 | ||
| Lacticaseibacillus rhamnosus GR-1 prevents autism-like behaviors by reshaping the maternal and offspring microbiome. | Yang R, Xu Y, Xu J, Huang C, Zhu F, Wang T, Kong R, Xiao J, He B, Gu X, Wang HL. | NPJ Biofilms Microbiomes | 10.1038/s41522-025-00808-5 | 2025 | ||
| Akkermansia muciniphila: new insights into resistance to gastrointestinal stress, adhesion, and protein interaction with human mucins through optimised in vitro trials and bioinformatics tools. | Vergalito F, Bagnoli D, Maiuro L, Pannella G, Palombo V, Testa B, Coppola F, Di Marco RMA, Tremonte P, Lombardi SJ, Iorizzo M, Coppola R, Succi M. | Front Microbiol | 10.3389/fmicb.2024.1462220 | 2024 | ||
| Akkermansia muciniphila ONE effectively ameliorates dextran sulfate sodium (DSS)-induced ulcerative colitis in mice. | Zhang H, Pan Y, Jiang Y, Chen M, Ma X, Yu X, Ren D, Jiang B. | NPJ Sci Food | 10.1038/s41538-024-00339-x | 2024 | ||
| Genetics | Investigation of Intestinal Microbiota and Short-Chain Fatty Acids in Colorectal Cancer and Detection of Biomarkers. | Saylam E, Ozden O, Yerlikaya FH, Sivrikaya A, Yormaz S, Arslan U, Topkafa M, Macin S. | Pathogens | 10.3390/pathogens14090953 | 2025 | |
| Probiotic administration aggravates dextran sulfate sodium salt-induced inflammation and intestinal epithelium disruption in weaned pig. | Xie K, Cai W, Li L, Yu B, Luo Y, Huang Z, Mao X, Yu J, Zheng P, Yan H, Li H, He J. | Anim Microbiome | 10.1186/s42523-024-00375-8 | 2025 | ||
| Function and therapeutic prospects of next-generation probiotic Akkermansia muciniphila in infectious diseases. | Li L, Li M, Chen Y, Yu Z, Cheng P, Yu Z, Cheng W, Zhang W, Wang Z, Gao X, Sun H, Wang X. | Front Microbiol | 10.3389/fmicb.2024.1354447 | 2024 | ||
| Pathogenicity | Development and characterization of a chicory extract fermented by Akkermansia muciniphila: An in vitro study on its potential to modulate obesity-related inflammation. | Chervet A, Nehme R, Defois-Fraysse C, Decombat C, Blavignac C, Auxenfans C, Evrard B, Michel S, Filaire E, Berthon JY, Dreux-Zigha A, Delort L, Caldefie-Chezet F. | Curr Res Food Sci | 10.1016/j.crfs.2025.100974 | 2025 | |
| Genetics | Genome- and Toxicology-Based Safety Assessment of Probiotic Akkermansia muciniphila ONE Isolated from Humans. | Lv N, Wang C, Zhou H, Ma X, Yu X, Ren D. | Foods | 10.3390/foods13131979 | 2024 | |
| Milk and mucin glycans orchestrate a synthetic infant gut microbiota structure. | Berkhout MD, Ioannou A, Kavanal Jayaprakash Y, Plugge CM, Belzer C. | FEMS Microbiol Ecol | 10.1093/femsec/fiaf069 | 2025 | ||
| Vitamin B12 analogues from gut microbes and diet differentially impact commensal propionate producers of the human gut. | Kundra P, Greppi A, Duppenthaler M, Pluss S, Pugin B, Lacroix C, Geirnaert A. | Front Nutr | 10.3389/fnut.2024.1360199 | 2024 | ||
| Lack of genotoxicity and subchronic toxicity in safety assessment studies of Akkermansia muciniphila formulation. | Yu E, Eid J, Cheng A, Lynch B, Bauter M. | Toxicol Rep | 10.1016/j.toxrep.2024.101790 | 2024 | ||
| Effects of Early Life Exposures to the Aryl Hydrocarbon Receptor Ligand TCDF on Gut Microbiota and Host Metabolic Homeostasis in C57BL/6J Mice. | Tian Y, Rimal B, Bisanz JE, Gui W, Wolfe TM, Koo I, Murray IA, Nettleford SK, Yokoyama S, Dong F, Koshkin S, Prabhu KS, Turnbaugh PJ, Walk ST, Perdew GH, Patterson AD. | Environ Health Perspect | 10.1289/ehp13356 | 2024 | ||
| Diet-driven differential response of Akkermansia muciniphila modulates pathogen susceptibility. | Wolter M, Grant ET, Boudaud M, Pudlo NA, Pereira GV, Eaton KA, Martens EC, Desai MS. | Mol Syst Biol | 10.1038/s44320-024-00036-7 | 2024 | ||
| Metabolism | Impaired Fat Absorption from Intestinal Tract in High-Fat Diet Fed Male Mice Deficient in Proglucagon-Derived Peptides. | Nishida K, Ueno S, Seino Y, Hidaka S, Murao N, Asano Y, Fujisawa H, Shibata M, Takayanagi T, Ohbayashi K, Iwasaki Y, Iizuka K, Okuda S, Tanaka M, Fujii T, Tochio T, Yabe D, Yamada Y, Sugimura Y, Hirooka Y, Hayashi Y, Suzuki A. | Nutrients | 10.3390/nu16142270 | 2024 | |
| Distinct in vitro utilization and degradation of porcine gastric mucin glycans by human intestinal bacteria. | de Ram C, Berkhout MD, O Pandeirada C, Vincken JP, Hooiveld GJEJ, Belzer C, Schols HA. | FEMS Microbiol Ecol | 10.1093/femsec/fiaf066 | 2025 | ||
| Genetics | Whole-genome sequencing and genomic analysis of four Akkermansia strains newly isolated from human feces. | Lu W, Zha B, Lyu J, LingHu C, Chen J, Deng S, Zhang X, Li L, Wang G. | Front Microbiol | 10.3389/fmicb.2024.1500886 | 2024 | |
| Physiology of gamma-aminobutyric acid production by Akkermansia muciniphila. | Konstanti P, Ligthart K, Fryganas C, Constantinos P, Smidt H, de Vos WM, Belzer C. | Appl Environ Microbiol | 10.1128/aem.01121-23 | 2024 | ||
| Phylogeny | Exploring the resilience and stability of a defined human gut microbiota consortium: An isothermal microcalorimetric study. | Kattel A, Aro V, Lahtvee PJ, Kazantseva J, Joers A, Nahku R, Belouah I. | Microbiologyopen | 10.1002/mbo3.1430 | 2024 | |
| Probiotics as Antioxidant Strategy for Managing Diabetes Mellitus and Its Complications. | Viana MDM, Santos SS, Cruz ABO, de Jesus MVAC, Lauria PSS, Lins MP, Villarreal CF. | Antioxidants (Basel) | 10.3390/antiox14070767 | 2025 | ||
| Possible application of Akkermansia muciniphila in stress management. | Misera A, Marlicz W, Podkowka A, Loniewski I, Skonieczna-Zydecka K. | Microbiome Res Rep | 10.20517/mrr.2023.81 | 2024 | ||
| The role of microbiota in nonalcoholic fatty liver disease: mechanism of action and treatment strategy | Shen S, Liu Y, Wang N, Huang Z, Deng G. | Front Microbiol | 2025 | |||
| Enzymology | In situ identifying sennoside A-reducing bacteria guilds in human gut microbiota via enzymatic activity visualization. | Zhai C, Liu X, Liu Z, Ma H, Li H, Gong Y, Li X, Wang Y, Zhang N, Zhang H, Luo G, Wang Y, Gao X. | Gut Microbes | 10.1080/19490976.2025.2560598 | 2025 | |
| Next-generation probiotic candidates targeting intestinal health in weaned piglets: Both live and heat-killed Akkermansia muciniphila prevent pathological changes induced by enterotoxigenic Escherichia coli in the gut. | Lan C, Li H, Shen Y, Liu Y, Wu A, He J, Cai J, Tian G, Mao X, Huang Z, Yu B, Zheng P, Yu J, Luo J, Yan H, Luo Y. | Anim Nutr | 10.1016/j.aninu.2024.01.007 | 2024 | ||
| Genetics | Characterization and Preliminary Safety Evaluation of Akkermansia muciniphila PROBIO. | Ma X, Tian M, Yu X, Liu M, Li B, Ren D, Wang W. | Foods | 10.3390/foods13030442 | 2024 | |
| Protocol for rapid obtention and fractionation of anaerobic bacterial conditioned media to study calcium signaling in enteroendocrine cells. | Amorim Neto DP, de Castro Fonseca M. | STAR Protoc | 10.1016/j.xpro.2022.101486 | 2022 | ||
| A Gnotobiotic Mouse Model with Divergent Equol-Producing Phenotypes: Potential for Determining Microbial-Driven Health Impacts of Soy Isoflavone Daidzein. | Leonard LM, Simpson AMR, Li S, Reddivari L, Cross TL. | Nutrients | 10.3390/nu16071079 | 2024 | ||
| Akkermansia muciniphila in inflammatory bowel disease and colorectal cancer. | Gu ZY, Pei WL, Zhang Y, Zhu J, Li L, Zhang Z. | Chin Med J (Engl) | 10.1097/cm9.0000000000001829 | 2021 | ||
| Clostridium butyricum and Clostridium tyrobutyricum: angel or devil for necrotizing enterocolitis? | Tao R, Zong G, Pan Y, Li H, Cheng P, Deng R, Chen W, Wang A, Xia S, Tang W, Lu Y, Wei Z. | mSystems | 10.1128/msystems.00732-23 | 2023 | ||
| Rational consideration of Akkermansia muciniphila targeting intestinal health: advantages and challenges. | Luo Y, Lan C, Li H, Ouyang Q, Kong F, Wu A, Ren Z, Tian G, Cai J, Yu B, He J, Wright AG. | NPJ Biofilms Microbiomes | 10.1038/s41522-022-00338-4 | 2022 | ||
| Safety Evaluation and Probiotic Potency Screening of Akkermansia muciniphila Strains Isolated from Human Feces and Breast Milk. | Hou F, Tang J, Liu Y, Tan Y, Wang Y, Zheng L, Liang D, Lin Y, Wang L, Pan Z, Yang R, Bi Y, Zhi F. | Microbiol Spectr | 10.1128/spectrum.03361-22 | 2023 | ||
| Akkermansia muciniphila Alters Gut Microbiota and Immune System to Improve Cardiovascular Diseases in Murine Model. | He X, Bai Y, Zhou H, Wu K. | Front Microbiol | 10.3389/fmicb.2022.906920 | 2022 | ||
| Exploring Next Generation Probiotics for Metabolic and Microbiota Dysbiosis Linked to Xenobiotic Exposure: Holistic Approach. | Torres-Sanchez A, Ruiz-Rodriguez A, Ortiz P, Moreno MA, Ampatzoglou A, Gruszecka-Kosowska A, Monteoliva-Sanchez M, Aguilera M. | Int J Mol Sci | 10.3390/ijms232112917 | 2022 | ||
| Akkermansia muciniphila inhibited the periodontitis caused by Fusobacterium nucleatum. | Song B, Xian W, Sun Y, Gou L, Guo Q, Zhou X, Ren B, Cheng L. | NPJ Biofilms Microbiomes | 10.1038/s41522-023-00417-0 | 2023 | ||
| Recent Advances in the Understanding of Stress Resistance Mechanisms in Probiotics: Relevance for the Design of Functional Food Systems. | Bustos AY, Taranto MP, Gerez CL, Agriopoulou S, Smaoui S, Varzakas T, Enshasy HAE. | Probiotics Antimicrob Proteins | 10.1007/s12602-024-10273-9 | 2025 | ||
| Akkermansia muciniphila induces mitochondrial calcium overload and alpha -synuclein aggregation in an enteroendocrine cell line. | Amorim Neto DP, Bosque BP, Pereira de Godoy JV, Rodrigues PV, Meneses DD, Tostes K, Costa Tonoli CC, Faustino de Carvalho H, Gonzalez-Billault C, de Castro Fonseca M. | iScience | 10.1016/j.isci.2022.103908 | 2022 | ||
| Phylogenetic diversity of core rumen microbiota as described by cryo-ET. | Wimmer BH, Morais S, Zalk R, Mizrahi I, Medalia O. | Microlife | 10.1093/femsml/uqad010 | 2023 | ||
| T-cell activation Rho GTPase-activating protein maintains intestinal homeostasis by regulating intestinal T helper cells differentiation through the gut microbiota. | He R, Chen J, Zhao Z, Shi C, Du Y, Yi M, Feng L, Peng Q, Cui Z, Gao R, Wang H, Huang Y, Liu Z, Wang C. | Front Microbiol | 10.3389/fmicb.2022.1030947 | 2022 | ||
| Akkermansia muciniphila Protects Against Psychological Disorder-Induced Gut Microbiota-Mediated Colonic Mucosal Barrier Damage and Aggravation of Colitis. | Chen T, Wang R, Duan Z, Yuan X, Ding Y, Feng Z, Bu F, Liu L, Wang Q, Zhou J, Zhu L, Ni Q, Shi G, Chen Y. | Front Cell Infect Microbiol | 10.3389/fcimb.2021.723856 | 2021 | ||
| Maternal diet and gut microbiome composition modulate early-life immune development. | Grant ET, Boudaud M, Muller A, Muller A, Macpherson AJ, Desai MS. | EMBO Mol Med | 10.15252/emmm.202217241 | 2023 | ||
| Transcriptome | The effect of bile acids on the growth and global gene expression profiles in Akkermansia muciniphila. | Hagi T, Geerlings SY, Nijsse B, Belzer C. | Appl Microbiol Biotechnol | 10.1007/s00253-020-10976-3 | 2020 | |
| Phylogeny | Pangenomic analysis identifies correlations between Akkermansia species and subspecies and human health outcomes. | Mueller KD, Panzetta ME, Davey L, McCann JR, Rawls JF, Flores GE, Valdivia RH. | Microbiome Res Rep | 10.20517/mrr.2024.09 | 2024 | |
| [Protective Effects of Akkermansia muciniphila and Amuc_1100 Protein on Rats on High-Fat Diet Combined with Streptozotocin Injection]. | Deng SS, Chen J, Liu X, Dong XY, Zhang XL, Wang GQ. | Sichuan Da Xue Xue Bao Yi Xue Ban | 10.12182/20220160304 | 2022 | ||
| Sialidases and fucosidases of Akkermansia muciniphila are crucial for growth on mucin and nutrient sharing with mucus-associated gut bacteria. | Shuoker B, Pichler MJ, Jin C, Sakanaka H, Wu H, Gascuena AM, Liu J, Nielsen TS, Holgersson J, Nordberg Karlsson E, Juge N, Meier S, Morth JP, Karlsson NG, Abou Hachem M. | Nat Commun | 10.1038/s41467-023-37533-6 | 2023 | ||
| Pathogenicity | Altered gut microbiota of obesity subjects promotes colorectal carcinogenesis in mice. | Kang X, Ng SK, Liu C, Lin Y, Zhou Y, Kwong TNY, Ni Y, Lam TYT, Wu WKK, Wei H, Sung JJY, Yu J, Wong SH. | EBioMedicine | 10.1016/j.ebiom.2023.104670 | 2023 | |
| The secreted protein Amuc_1409 from Akkermansia muciniphila improves gut health through intestinal stem cell regulation. | Kang EJ, Kim JH, Kim YE, Lee H, Jung KB, Chang DH, Lee Y, Park S, Lee EY, Lee EJ, Kang HB, Rhyoo MY, Seo S, Park S, Huh Y, Go J, Choi JH, Choi YK, Lee IB, Choi DH, Seo YJ, Noh JR, Kim KS, Hwang JH, Jeong JS, Kwon HJ, Yoo HM, Son MY, Kim YG, Lee DH, Kim TY, Kwon HJ, Kim MH, Kim BC, Kim YH, Kang D, Lee CH. | Nat Commun | 10.1038/s41467-024-47275-8 | 2024 | ||
| Phylogeny | Comprehensive 16S rRNA and metagenomic data from the gut microbiome of aging and rejuvenation mouse models. | Shin J, Noh JR, Choe D, Lee N, Song Y, Cho S, Kang EJ, Go MJ, Ha SK, Kim JH, Kim YH, Kim KS, Kim BC, Lee CH, Cho BK. | Sci Data | 10.1038/s41597-022-01308-3 | 2022 | |
| Proanthocyanidin-enriched cranberry extract induces resilient bacterial community dynamics in a gnotobiotic mouse model. | Neto CC, Mortzfeld BM, Turbitt JR, Bhattarai SK, Yeliseyev V, DiBenedetto N, Bry L, Bucci V. | Microb Cell | 10.15698/mic2021.06.752 | 2021 | ||
| Pathogenicity | Active or Autoclaved Akkermansia muciniphila Relieves TNF-alpha-Induced Inflammation in Intestinal Epithelial Cells Through Distinct Pathways. | Luo Y, Lan C, Xie K, Li H, Devillard E, He J, Liu L, Cai J, Tian G, Wu A, Ren Z, Chen D, Yu B, Huang Z, Zheng P, Mao X, Yu J, Luo J, Yan H, Wang Q, Wang H, Tang J. | Front Immunol | 10.3389/fimmu.2021.788638 | 2021 | |
| Downregulation of ACE, AGTR1, and ACE2 genes mediating SARS-CoV-2 pathogenesis by gut microbiota members and their postbiotics on Caco-2 cells. | Ahmadi Badi S, Malek A, Paolini A, Rouhollahi Masoumi M, Seyedi SA, Amanzadeh A, Masotti A, Khatami S, Siadat SD. | Microb Pathog | 10.1016/j.micpath.2022.105798 | 2022 | ||
| Specific gFET-Based Aptasensors for Monitoring of Microbiome Quality: Quantification of the Enteric Health-Relevant Bacterium Roseburia Intestinalis. | Zhang Y, Xing H, Li R, Andersson J, Bozdogan A, Strassl R, Draphoen B, Linden M, Henkel M, Knippschild U, Hasler R, Kleber C, Knoll W, Kissmann AK, Rosenau F. | Adv Healthc Mater | 10.1002/adhm.202403827 | 2025 | ||
| Metabolism | Transcriptomics and metabolomics reveal the adaption of Akkermansia muciniphila to high mucin by regulating energy homeostasis. | Liu X, Zhao F, Liu H, Xie Y, Zhao D, Li C. | Sci Rep | 10.1038/s41598-021-88397-z | 2021 | |
| Mucosal glycan degradation of the host by the gut microbiota. | Bell A, Juge N. | Glycobiology | 10.1093/glycob/cwaa097 | 2021 | ||
| Pathogenicity | Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients. | Daisley BA, Chanyi RM, Abdur-Rashid K, Al KF, Gibbons S, Chmiel JA, Wilcox H, Reid G, Anderson A, Dewar M, Nair SM, Chin J, Burton JP. | Nat Commun | 10.1038/s41467-020-18649-5 | 2020 | |
| Transcriptome | Simplified Intestinal Microbiota to Study Microbe-Diet-Host Interactions in a Mouse Model. | Kovatcheva-Datchary P, Shoaie S, Lee S, Wahlstrom A, Nookaew I, Hallen A, Perkins R, Nielsen J, Backhed F. | Cell Rep | 10.1016/j.celrep.2019.02.090 | 2019 | |
| Versatility of bacterial outer membrane vesicles in regulating intestinal homeostasis. | Wang X, Lin S, Wang L, Cao Z, Zhang M, Zhang Y, Liu R, Liu J. | Sci Adv | 10.1126/sciadv.ade5079 | 2023 | ||
| Mucolytic bacteria license pathobionts to acquire host-derived nutrients during dietary nutrient restriction. | Sugihara K, Kitamoto S, Saraithong P, Nagao-Kitamoto H, Hoostal M, McCarthy C, Rosevelt A, Muraleedharan CK, Gillilland MG, Imai J, Omi M, Bishu S, Kao JY, Alteri CJ, Barnich N, Schmidt TM, Nusrat A, Inohara N, Golob JL, Kamada N. | Cell Rep | 10.1016/j.celrep.2022.111093 | 2022 | ||
| Metabolism | Prevalent Human Gut Bacteria Hydrolyse and Metabolise Important Food-Derived Mycotoxins and Masked Mycotoxins. | Daud N, Currie V, Duncan G, Farquharson F, Yoshinari T, Louis P, Gratz S. | Toxins (Basel) | 10.3390/toxins12100654 | 2020 | |
| Xylanase enhances gut microbiota-derived butyrate to exert immune-protective effects in a histone deacetylase-dependent manner. | Wang T, Zhou N, Ding F, Hao Z, Galindo-Villegas J, Du Z, Su X, Zhang M. | Microbiome | 10.1186/s40168-024-01934-6 | 2024 | ||
| Metabolism | Identification of a Novel Cobamide Remodeling Enzyme in the Beneficial Human Gut Bacterium Akkermansia muciniphila. | Mok KC, Sokolovskaya OM, Nicolas AM, Hallberg ZF, Deutschbauer A, Carlson HK, Taga ME. | mBio | 10.1128/mbio.02507-20 | 2020 | |
| Propionate-Producing Consortium Restores Antibiotic-Induced Dysbiosis in a Dynamic in vitro Model of the Human Intestinal Microbial Ecosystem. | El Hage R, Hernandez-Sanabria E, Calatayud Arroyo M, Props R, Van de Wiele T. | Front Microbiol | 10.3389/fmicb.2019.01206 | 2019 | ||
| Short-chain fatty acid-producing bacterial strains attenuate experimental ulcerative colitis by promoting M2 macrophage polarization via JAK/STAT3/FOXO3 axis inactivation. | Zhao H, Zhou Y, Xu J, Zhang Y, Wang H, Zhao C, Huang H, Yang J, Huang C, Li Y, Wang L, Nie Y. | J Transl Med | 10.1186/s12967-024-05122-w | 2024 | ||
| Pathogenicity | Constructing a gnotobiotic mouse model with a synthetic human gut microbiome to study host-microbe cross talk. | Steimle A, De Sciscio A, Neumann M, Grant ET, Pereira GV, Ohno H, Martens EC, Desai MS. | STAR Protoc | 10.1016/j.xpro.2021.100607 | 2021 | |
| The immunotoxicity, but not anti-tumor efficacy, of anti-CD40 and anti-CD137 immunotherapies is dependent on the gut microbiota. | Blake SJ, James J, Ryan FJ, Caparros-Martin J, Eden GL, Tee YC, Salamon JR, Benson SC, Tumes DJ, Sribnaia A, Stevens NE, Finnie JW, Kobayashi H, White DL, Wesselingh SL, O'Gara F, Lynn MA, Lynn DJ. | Cell Rep Med | 10.1016/j.xcrm.2021.100464 | 2021 | ||
| Assessment of Gram- and Viability-Staining Methods for Quantifying Bacterial Community Dynamics Using Flow Cytometry. | Duquenoy A, Bellais S, Gasc C, Schwintner C, Dore J, Thomas V. | Front Microbiol | 10.3389/fmicb.2020.01469 | 2020 | ||
| How microbial glycosyl hydrolase activity in the gut mucosa initiates microbial cross-feeding. | Berkhout MD, Plugge CM, Belzer C. | Glycobiology | 10.1093/glycob/cwab105 | 2022 | ||
| Metabolism | Biochemical and structural basis of sialic acid utilization by gut microbes. | Bell A, Severi E, Owen CD, Latousakis D, Juge N. | J Biol Chem | 10.1016/j.jbc.2023.102989 | 2023 | |
| Metabolism | Butyrate producing colonic Clostridiales metabolise human milk oligosaccharides and cross feed on mucin via conserved pathways. | Pichler MJ, Yamada C, Shuoker B, Alvarez-Silva C, Gotoh A, Leth ML, Schoof E, Katoh T, Sakanaka M, Katayama T, Jin C, Karlsson NG, Arumugam M, Fushinobu S, Abou Hachem M. | Nat Commun | 10.1038/s41467-020-17075-x | 2020 | |
| Cross-generational bacterial strain transfer to an infant after fecal microbiota transplantation to a pregnant patient: a case report. | Wei S, Jespersen ML, Baunwall SMD, Myers PN, Smith EM, Dahlerup JF, Rasmussen S, Nielsen HB, Licht TR, Bahl MI, Hvas CL. | Microbiome | 10.1186/s40168-022-01394-w | 2022 | ||
| Perturbed Microbiota/Immune Homeostasis in Multiple Sclerosis. | Sterlin D, Larsen M, Fadlallah J, Parizot C, Vignes M, Autaa G, Dorgham K, Juste C, Lepage P, Aboab J, Vicart S, Maillart E, Gout O, Lubetzki C, Deschamps R, Papeix C, Gorochov G. | Neurol Neuroimmunol Neuroinflamm | 10.1212/nxi.0000000000000997 | 2021 | ||
| Metabolism | SIMMER employs similarity algorithms to accurately identify human gut microbiome species and enzymes capable of known chemical transformations. | Bustion AE, Nayak RR, Agrawal A, Turnbaugh PJ, Pollard KS. | Elife | 10.7554/elife.82401 | 2023 | |
| Metabolism | Differential effects of coconut versus soy oil on gut microbiota composition and predicted metabolic function in adult mice. | Patrone V, Minuti A, Lizier M, Miragoli F, Lucchini F, Trevisi E, Rossi F, Callegari ML. | BMC Genomics | 10.1186/s12864-018-5202-z | 2018 | |
| Development of an in vitro Model of Human Gut Microbiota for Screening the Reciprocal Interactions With Antibiotics, Drugs, and Xenobiotics. | El Houari A, Ecale F, Mercier A, Crapart S, Laparre J, Soulard B, Ramnath M, Berjeaud JM, Rodier MH, Crepin A. | Front Microbiol | 10.3389/fmicb.2022.828359 | 2022 | ||
| Commensal Obligate Anaerobic Bacteria and Health: Production, Storage, and Delivery Strategies. | Andrade JC, Almeida D, Domingos M, Seabra CL, Machado D, Freitas AC, Gomes AM. | Front Bioeng Biotechnol | 10.3389/fbioe.2020.00550 | 2020 | ||
| Metabolism | Rational design of a microbial consortium of mucosal sugar utilizers reduces Clostridiodes difficile colonization. | Pereira FC, Wasmund K, Cobankovic I, Jehmlich N, Herbold CW, Lee KS, Lee KS, Sziranyi B, Vesely C, Decker T, Stocker R, Warth B, von Bergen M, Wagner M, Berry D. | Nat Commun | 10.1038/s41467-020-18928-1 | 2020 | |
| Metabolism | Paneth Cell-Derived Lysozyme Defines the Composition of Mucolytic Microbiota and the Inflammatory Tone of the Intestine. | Yu S, Balasubramanian I, Laubitz D, Tong K, Bandyopadhyay S, Lin X, Flores J, Singh R, Liu Y, Macazana C, Zhao Y, Beguet-Crespel F, Patil K, Midura-Kiela MT, Wang D, Yap GS, Ferraris RP, Wei Z, Bonder EM, Haggblom MM, Zhang L, Douard V, Verzi MP, Cadwell K, Kiela PR, Gao N. | Immunity | 10.1016/j.immuni.2020.07.010 | 2020 | |
| Bifidobacteria support optimal infant vaccine responses. | Ryan FJ, Clarke M, Lynn MA, Benson SC, McAlister S, Giles LC, Choo JM, Rossouw C, Ng YY, Semchenko EA, Richard A, Leong LEX, Taylor SL, Blake SJ, Mugabushaka JI, Walker M, Wesselingh SL, Licciardi PV, Seib KL, Tumes DJ, Richmond P, Rogers GB, Marshall HS, Lynn DJ. | Nature | 10.1038/s41586-025-08796-4 | 2025 | ||
| Enzymology | Sialidases from gut bacteria: a mini-review. | Juge N, Tailford L, Owen CD. | Biochem Soc Trans | 10.1042/bst20150226 | 2016 | |
| Enzymology | Degradation of the low-calorie sugar substitute 5-ketofructose by different bacteria. | Schiessl J, Kosciow K, Garschagen LS, Hoffmann JJ, Heymuth J, Franke T, Deppenmeier U. | Appl Microbiol Biotechnol | 10.1007/s00253-021-11168-3 | 2021 | |
| Developing standards for the microbiome field. | Amos GCA, Logan A, Anwar S, Fritzsche M, Mate R, Bleazard T, Rijpkema S. | Microbiome | 10.1186/s40168-020-00856-3 | 2020 | ||
| Selection of cross-reactive T cells by commensal and food-derived yeasts drives cytotoxic TH1 cell responses in Crohn's disease. | Martini GR, Tikhonova E, Rosati E, DeCelie MB, Sievers LK, Tran F, Lessing M, Bergfeld A, Hinz S, Nikolaus S, Kumpers J, Matysiak A, Hofmann P, Saggau C, Schneiders S, Kamps AK, Jacobs G, Lieb W, Maul J, Siegmund B, Seegers B, Hinrichsen H, Oberg HH, Wesch D, Bereswill S, Heimesaat MM, Rupp J, Kniemeyer O, Brakhage AA, Brunke S, Hube B, Aden K, Franke A, Iliev ID, Scheffold A, Schreiber S, Bacher P. | Nat Med | 10.1038/s41591-023-02556-5 | 2023 | ||
| Phylogeny | Cooking shapes the structure and function of the gut microbiome. | Carmody RN, Bisanz JE, Bowen BP, Maurice CF, Lyalina S, Louie KB, Treen D, Chadaideh KS, Maini Rekdal V, Bess EN, Spanogiannopoulos P, Ang QY, Bauer KC, Balon TW, Pollard KS, Northen TR, Turnbaugh PJ. | Nat Microbiol | 10.1038/s41564-019-0569-4 | 2019 | |
| Metabolism | Phylogenetic distribution of three pathways for propionate production within the human gut microbiota. | Reichardt N, Duncan SH, Young P, Belenguer A, McWilliam Leitch C, Scott KP, Flint HJ, Louis P. | ISME J | 10.1038/ismej.2014.14 | 2014 | |
| Pathogenicity | The Use of Defined Microbial Communities To Model Host-Microbe Interactions in the Human Gut. | Elzinga J, van der Oost J, de Vos WM, Smidt H. | Microbiol Mol Biol Rev | 10.1128/mmbr.00054-18 | 2019 | |
| Metabolism | Methotrexate impacts conserved pathways in diverse human gut bacteria leading to decreased host immune activation. | Nayak RR, Alexander M, Deshpande I, Stapleton-Gray K, Rimal B, Patterson AD, Ubeda C, Scher JU, Turnbaugh PJ. | Cell Host Microbe | 10.1016/j.chom.2020.12.008 | 2021 | |
| Therapeutic potential of Akkermansia muciniphila in non-alcoholic fatty liver disease: a systematic review. | Asghari P, Ahmadi-Khorram M, Hatami A, Talebi S, Afshari A. | BMC Gastroenterol | 10.1186/s12876-025-04436-3 | 2025 | ||
| Safety of an extension of use of pasteurised Akkermansia muciniphila as a novel food pursuant to Regulation (EU) 2015/2283. | EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Turck D, Bohn T, Camara M, Castenmiller J, De Henauw S, Jos A, Maciuk A, Mangelsdorf I, McNulty B, Naska A, Pentieva K, Siani A, Thies F, Aguilera-Gomez M, Frenzel T, Marcon F, McArdle HJ, Moldeus P, Neuhauser-Berthold M, Poulsen M, Prieto Maradona M, Schlatter JR, van Loveren H, Ackerl R, Hirsch-Ernst KI. | EFSA J | 10.2903/j.efsa.2025.9632 | 2025 | ||
| Transcriptome | Effects of Akkermansia muciniphila on growth, antioxidant status and jejunal transcriptome in LPS-stressed yellow-feathered broilers. | Zhu R, Jing Y, Tang J, Ou L, Zou Z, Luo C, Qi Q, Feng X. | Poult Sci | 10.1016/j.psj.2025.105954 | 2025 | |
| Advancements in understanding the relationship between Akkermansia muciniphila and the development of ulcerative colitis. | Xu N, Xiao X, Ma Y, Jing J, Jiang S, Luo K, Li Y, Duan M. | Front Pediatr | 10.3389/fped.2025.1673156 | 2025 | ||
| Metabolism | Investigating the role of Akkermansia muciniphila Akk11 in modulating obesity and intestinal dysbiosis: a comparative study of live and pasteurized treatments. | Feng S, Wang W, Zhang X, Helal SE, Peng N, Zhang Z. | Front Microbiol | 10.3389/fmicb.2025.1638771 | 2025 | |
| Membrane vesicles produced by next-generation probiotics from the gut as innovative tools for human health. | Abraham L, Raise A, Beney L, Lapaquette P, Rieu A. | Gut Microbes | 10.1080/19490976.2025.2552344 | 2025 | ||
| Akkermansia muciniphila-derived hypoacylated rough-type lipopolysaccharides alleviate diet-induced obesity via activation of TLR4-IL-23-IL-22 immune axis. | Sun L, Zhang Y, Dong W, Sun J, Wang T, Shao F, Dai H, Han J, Wang W, Wang S, Zhao T, Wang L, Liu C, Liu S, Liu H. | Imeta | 10.1002/imt2.70066 | 2025 | ||
| Live Akkermansia muciniphila boosts dendritic cell retinoic acid synthesis to modulate IL-22 activity and mitigate colitis in mice. | Liu H, Huang R, Shen B, Huang C, Zhou Q, Xu J, Chen S, Lin X, Wang J, Zhao X, Guo Y, Ai X, Liu Y, Wang Y, Zhang W, Zhi F. | Microbiome | 10.1186/s40168-024-01995-7 | 2024 | ||
| The pathobiont role of Akkermansia muciniphila in colorectal cancer: a systematic review. | Soheilipour M, Noursina A, Nekookhoo M, Malekpour E, Mirzaei SA, Shafieyoun MH, Rouzbahani H, Chitsazi MR, Safari F. | BMC Gastroenterol | 10.1186/s12876-025-04293-0 | 2025 | ||
| Pathogenicity | The biofunction of Akkermansia muciniphila in intestinal-related diseases. | Jiang P, Ji S, Su D, Zhao Y, Goncalves VBE, Xu G, Zhang M. | Microbiome Res Rep | 10.20517/mrr.2024.12 | 2024 | |
| Akkermansia muciniphila: a microbial guardian against oxidative stress-gut microbiota crosstalk and clinical prospects. | Ye WY, Cai Y. | J Transl Med | 10.1186/s12967-025-07149-z | 2025 | ||
| The role of Akkermansia muciniphila in maintaining health: a bibliometric study. | Gao F, Cheng C, Li R, Chen Z, Tang K, Du G. | Front Med (Lausanne) | 10.3389/fmed.2025.1484656 | 2025 | ||
| Akkermansia muciniphila ameliorates chronic stress-induced colorectal tumor growth by releasing outer membrane vesicles. | Jin S, Lu Y, Zuo Y, Xu Q, Hao Y, Zuo H, Cui Z, Zhang X, Wang M, Li H, Wang S, Li Y. | Gut Microbes | 10.1080/19490976.2025.2555618 | 2025 | ||
| Pathogenicity | Akkermansia muciniphila alleviates cognitive impairment and neuroinflammation induced by blunt chest trauma. | Liu L, Wang L, Wang Y, Zhao H, Gao X, Yin W, Xie J. | Front Immunol | 10.3389/fimmu.2025.1657524 | 2025 | |
| Pasteurized Akkermansia muciniphila Timepie001 ameliorates DSS-induced ulcerative colitis in mice by alleviating intestinal injury and modulating gut microbiota. | Han H, Xiong H, Liu Z, Liu X, Wang H, Kou J, Yi D, Shi Y, Wu H, Qiao J. | Front Microbiol | 10.3389/fmicb.2025.1542522 | 2025 | ||
| Enhancing immunotherapy efficacy in NSCLC through the combined use of phenelzine and Akkermansia muciniphila to regulate gut microbial metabolite 5-HIAA. | Sun S, Wang L, Cui K, Ding Y, Wei Y, Zheng Y, Shen Z, Zhu L, Yang Y, Yu P, Song Y, Chao K, Zhang Y, Ge Y, Ji W, Li C, Sethi G, Li L, Zhao J. | J Immunother Cancer | 10.1136/jitc-2025-011831 | 2025 | ||
| Metabolism | The Positive Effect of Akkermansia muciniphila postbiotics on the Glycolipid Metabolism of Caenorhabditis elegans Induced by High-Glucose Diet. | Wu Z, Li K, Hou A, Wang Y, Li Z. | Nutrients | 10.3390/nu17060976 | 2025 | |
| Genetics | Genomic Face-off: An In Silico Comparison of the Probiotic Potential of Lactobacillus spp. and Akkermansia muciniphila. | Fakruddin M, Abu Bakar Karim M, Islam BU, Safa A, Sultana J, Bulbul N, Shishir MA. | Curr Genomics | 10.2174/0113892029317403240815044408 | 2025 | |
| Genetics | Deep sequencing-derived Metagenome Assembled Genomes from the gut microbiome of liver transplant patients. | Banerjee G, Papri SR, Huang H, Satapathy SK, Banerjee P. | Sci Data | 10.1038/s41597-024-04153-8 | 2025 | |
| Antibiotic-associated changes in Akkermansia muciniphila alter its effects on host metabolic health. | Han Y, Teng TM, Han J, Kim HS. | Microbiome | 10.1186/s40168-024-02023-4 | 2025 | ||
| Heterocyclic Antidepressants with Antimicrobial and Fungicide Activity. | Zolotareva D, Zazybin A, Belyankova Y, Bayazit S, Dauletbakov A, Seilkhanov T, Kemelbekov U, Aydemir M. | Molecules | 10.3390/molecules30051102 | 2025 | ||
| Big lessons from the little Akkermansia muciniphila in hepatocellular carcinoma. | Yang Y, Shi X. | Front Immunol | 10.3389/fimmu.2025.1524563 | 2025 | ||
| Comprehensive profiling of genomic invertons in defined gut microbial community reveals associations with intestinal colonization and surface adhesion. | Jin X, Cheng AG, Chanin RB, Yu FB, Dimas A, Jasper M, Weakley A, Yan J, Bhatt AS, Pollard KS. | Microbiome | 10.1186/s40168-025-02052-7 | 2025 | ||
| Pasteurized Akkermansia muciniphila Ameliorates Preeclampsia in Mice by Enhancing Gut Barrier Integrity, Improving Endothelial Function, and Modulating Gut Metabolic Dysregulation. | Peng L, Yin Q, Wang X, Zhong Y, Wang Y, Cai W, Zhou R, Chen Y, Hu Y, Cheng Z, Jiang W, Yue X, Huang L. | Microorganisms | 10.3390/microorganisms12122483 | 2024 | ||
| Akkermansia muciniphila in the small intestine improves liver fibrosis in a murine liver cirrhosis model. | Oguri N, Miyoshi J, Nishinarita Y, Wada H, Nemoto N, Hibi N, Kawamura N, Miyoshi S, Lee STM, Matsuura M, Osaki T, Hisamatsu T. | NPJ Biofilms Microbiomes | 10.1038/s41522-024-00564-y | 2024 | ||
| Akkermansia muciniphila-Derived N-Acetylspermidine Modulates the Localization of Intestinal alpha1,2-Fucosylated Proteins to Maintain Gut Homeostasis. | Yao Y, Pei Z, Dai Y, Chen Y, Chang Z, Wang H, Zhao J, Zhang H, Zhai Q, Lu W, Chen W. | Adv Sci (Weinh) | 10.1002/advs.202506576 | 2025 | ||
| Carbohydrate-active enzymes from Akkermansia muciniphila break down mucin O-glycans to completion. | Bakshani CR, Ojuri TO, Pilgaard B, Holck J, McInnes R, Kozak RP, Zakhour M, Cakaj S, Kerouedan M, Newton E, Bolam DN, Crouch LI. | Nat Microbiol | 10.1038/s41564-024-01911-7 | 2025 | ||
| Rehydration Beverages Made from Quercus sideroxyla Infusion, Probiotics, and Prebiotics: Antioxidant and Anti-Inflammatory Potential. | Salas-Ramirez CA, Moreno-Jimenez MR, Rocha-Guzman NE, Gallegos-Infante JA, Gonzalez-Laredo RF, Gonzalez Herrera SM, Gonzalez-Mercado ME, Herrera-Rocha KM, Chairez-Ramirez MH. | Foods | 10.3390/foods14050837 | 2025 | ||
| Akkermansia muciniphila and its metabolite propionic acid maintains neuronal mitochondrial division and autophagy homeostasis during Alzheimer's disease pathologic process via GPR41 and GPR43. | Wang Z, Wang C, Yuan B, Liu L, Zhang H, Zhu M, Chai H, Peng J, Huang Y, Zhou S, Liu J, Wu L, Wang W. | Microbiome | 10.1186/s40168-024-02001-w | 2025 | ||
| Akkermansia muciniphila MucT harnesses dietary polyphenols as xenosiderophores for enhanced iron uptake. | Rodriguez-Daza MC, Boeren S, Tytgat HLP, Desjardins Y, de Vos WM. | Nat Commun | 10.1038/s41467-025-64477-w | 2025 | ||
| Allobaculum mucilyticum-Mediated Gut Barrier Dysfunction Exacerbates the Severity of Hypertriglyceridemic Acute Pancreatitis in Mice. | Yang P, Wu M, Liang W, Sun Y, Pan LL, Sun J. | Antioxidants (Basel) | 10.3390/antiox14111284 | 2025 | ||
| Integrated metabolomics and the microbiome reveal the compatibility mechanism of the Suxiao Jiuxin pill in the treatment of stable coronary artery disease. | Le W, Liao J, Zhang Y, Xu J, Zeng Y, Li H, Shen X, Wu G, Zhang W. | Chin Med | 10.1186/s13020-025-01198-8 | 2025 | ||
| Characterization and Anti-Inflammatory Effects of Akkermansia muciniphila-Derived Extracellular Vesicles. | Zhao S, Xiang J, Abedin M, Wang J, Zhang Z, Zhang Z, Wu H, Xiao J. | Microorganisms | 10.3390/microorganisms13020464 | 2025 | ||
| Genetics | O-Mucin-degrading carbohydrate-active enzymes and their possible implication in inflammatory bowel diseases. | Labourel A, Parrou JL, Deraison C, Mercier-Bonin M, Lajus S, Potocki-Veronese G. | Essays Biochem | 10.1042/ebc20220153 | 2023 | |
| Akkermansia mono-colonization modulates microglia and astrocytes in a strain specific manner. | Schwerdtfeger LA, Lanser TB, Montini F, Moreira T, LeServe DS, Cox LM, Weiner HL. | J Neuroinflammation | 10.1186/s12974-025-03417-3 | 2025 | ||
| Dietary Selenium Deficiency Accelerates the Onset of Aging-Related Gut Microbial Changes in Aged Telomere-Humanized Mice, With Akkermansia muciniphila Being the Most Prominent and Alleviating Selenium Deficiency-Induced Type 2 Diabetes. | Huang YC, Lu HY, Zhang L, Olivier A, Wu TL, Hsu CY, LeGrand C, Zeng H, Curran S, Wang Q, Nannapaneni R, Zhang X, Tico M, Mariotti M, Wu RTY, Combs GF, Cheng WH. | Aging Cell | 10.1111/acel.70130 | 2025 | ||
| The Effect of Photobiomodulation and Akkermansia muciniphila on THP-1 Derived Macrophage Polarization Treated with Gliadin Peptide. | Jahani-Sherafat S, Mollaghaei S, Asri N, Rezaei Tavirani M, Baghaei K, Rostami-Nejad M. | J Lasers Med Sci | 10.34172/jlms.2024.21 | 2024 | ||
| Akkermansia muciniphila Metabolite Inosine Inhibits Castration Resistance in Prostate Cancer. | Yu Y, Li L, Yang Q, Xue J, Wang B, Xie M, Shangguan W, Zhu Z, Wu P. | Microorganisms | 10.3390/microorganisms12081653 | 2024 | ||
| Oral Combined Probiotics Clostridium butyricum and Akkermansia muciniphila Inhibits the Progression of 4T1 Breast Cancer by Activating Bcl-2/Bax Pathway. | Li X, Hua D, Wu D, Hong W, Kang Y, Tang L, Yang Q, Wang X, Li B, Li R, Chen Z, Cui G. | Cancer Med | 10.1002/cam4.70987 | 2025 | ||
| Phylogeny | Optimizing Akkermansia muciniphila Isolation and Cultivation: Insights into Gut Microbiota Composition and Potential Growth Promoters in a Chinese Cohort. | Meng X, Xv C, Lv J, Zhang S, Ma C, Pang X. | Microorganisms | 10.3390/microorganisms12050881 | 2024 | |
| Biotechnology | Omics-based analysis of Akkermansia muciniphila cultivation in food-grade media. | Geerlings SY, van der Ark K, Nijsse B, Boeren S, van Loosdrecht M, Belzer C, de Vos WM. | Microbiome Res Rep | 10.20517/mrr.2024.06 | 2024 | |
| Postbiotics: a perspective on their quantification. | Vinderola G, Benkowski A, Bernardeau M, Chenoll E, Collado MC, Cronin U, Eckhardt E, Green JB, Ipharraguerre IR, Kemperman R, Lacroix C, Minami J, Wilkinson M, Sanders ME, Salminen S. | Front Nutr | 10.3389/fnut.2025.1582733 | 2025 | ||
| Gut-derived lactic acid enhances tryptophan to 5-hydroxytryptamine in regulation of anxiety via Akkermansia muciniphila. | Pan M, Qian C, Huo S, Wu Y, Zhao X, Ying Y, Wang B, Yang H, Yeerken A, Wang T, Fu M, Wang L, Wei Y, Zhao Y, Shao C, Wang H, Zhao C. | Gut Microbes | 10.1080/19490976.2024.2447834 | 2025 | ||
| Peptidoglycan from Akkermansia muciniphila MucT: chemical structure and immunostimulatory properties of muropeptides. | Garcia-Vello P, Tytgat HLP, Gray J, Elzinga J, Di Lorenzo F, Biboy J, Vollmer D, De Castro C, Vollmer W, de Vos WM, Molinaro A. | Glycobiology | 10.1093/glycob/cwac027 | 2022 | ||
| [Akkermansia muciniphila gavage improves gut-brain interaction disorders in gp120 transgenic mice]. | Luo J, Batzaya S, Gao X, Chen J, Yu Z, Xiong S, Cao H. | Nan Fang Yi Ke Da Xue Xue Bao | 10.12122/j.issn.1673-4254.2025.03.13 | 2025 | ||
| Emerging Roles of the Gut Microbiome in Musculoskeletal Injury and Repair. | Roberts JL, Park CC. | Microorganisms | 10.3390/microorganisms13092193 | 2025 | ||
| Function of Akkermansia muciniphila in type 2 diabetes and related diseases. | Li J, Yang G, Zhang Q, Liu Z, Jiang X, Xin Y. | Front Microbiol | 10.3389/fmicb.2023.1172400 | 2023 | ||
| Carbon dioxide enhances Akkermansia muciniphila fitness and anti-obesity efficacy in high-fat diet mice. | Wang X, Yang Q, Shi C, Wang Y, Guo D, Wan X, Dong P, Zhang Q, Hu Y, Zhang R, Yang H, Chen W, Liu Z. | ISME J | 10.1093/ismejo/wraf034 | 2025 | ||
| Pathogenicity | The Role of Akkermansia muciniphila on Improving Gut and Metabolic Health Modulation: A Meta-Analysis of Preclinical Mouse Model Studies. | Khalili L, Park G, Nagpal R, Salazar G. | Microorganisms | 10.3390/microorganisms12081627 | 2024 | |
| Pathogenicity | Akkermansia muciniphila - friend or foe in colorectal cancer? | Gubernatorova EO, Gorshkova EA, Bondareva MA, Podosokorskaya OA, Sheynova AD, Yakovleva AS, Bonch-Osmolovskaya EA, Nedospasov SA, Kruglov AA, Drutskaya MS. | Front Immunol | 10.3389/fimmu.2023.1303795 | 2023 | |
| Genetics | Akkermansia muciniphila Exerts Strain-Specific Effects on DSS-Induced Ulcerative Colitis in Mice. | Liu Q, Lu W, Tian F, Zhao J, Zhang H, Hong K, Yu L. | Front Cell Infect Microbiol | 10.3389/fcimb.2021.698914 | 2021 | |
| Structural and functional insights into metal coordination and substrate recognition of Akkermansia muciniphila sialidase Amuc_1547. | Li T, Tang X, Zhu Y, Zhao N, Song Y, He L, Mou X, Ge C, Chen Z, Zhang H, Yao X, Hu X, Cheng J, Yao H, Bao R. | Mol Biomed | 10.1186/s43556-025-00265-8 | 2025 | ||
| Proteome | Nutrient-specific proteomic analysis of the mucin degrading bacterium Akkermansia muciniphila. | Lee JY, Jin HS, Kim KS, Baek JH, Kim BS, Lee DW. | Proteomics | 10.1002/pmic.202100125 | 2022 | |
| Synthetic microbial community improves chicken intestinal homeostasis and provokes anti-Salmonella immunity mediated by segmented filamentous bacteria. | Zhang M, Shi S, Feng Y, Zhang F, Xiao Y, Li X, Pan X, Feng Y, Liu D, Guo Y, Hu Y. | ISME J | 10.1093/ismejo/wraf076 | 2025 | ||
| Pathogenicity | Akkermansia muciniphila exacerbates acute radiation-induced intestinal injury by depleting mucin and enhancing inflammation. | Wang Y, Wang X, Chen Z, Zheng J, Liu X, Zheng Y, Zheng Z, Xu Z, Zhang Y, Chen K, Zhang Y, Yu L, Ding Y. | ISME J | 10.1093/ismejo/wraf084 | 2025 | |
| Community metabolic modeling of host-microbiota interactions through multi-objective optimization. | Lambert A, Budinich M, Mahe M, Chaffron S, Eveillard D. | iScience | 10.1016/j.isci.2024.110092 | 2024 | ||
| Pathogenicity | Akkermansia muciniphila-induced trained immune phenotype increases bacterial intracellular survival and attenuates inflammation. | Pena-Cearra A, Palacios A, Pellon A, Castelo J, Pasco ST, Seoane I, Barriales D, Martin JE, Pascual-Itoiz MA, Gonzalez-Lopez M, Martin-Ruiz I, Macias-Camara N, Gutiez N, Araujo-Aris S, Aransay AM, Rodriguez H, Anguita J, Abecia L. | Commun Biol | 10.1038/s42003-024-05867-6 | 2024 | |
| Health Effects and Therapeutic Potential of the Gut Microbe Akkermansia muciniphila. | Aja E, Zeng A, Gray W, Connelley K, Chaganti A, Jacobs JP. | Nutrients | 10.3390/nu17030562 | 2025 | ||
| Akkermansia muciniphila supplementation improves glucose tolerance in intestinal Ffar4 knockout mice during the daily light to dark transition. | Wang Z, Cui S, Zhang T, Wang W, Li J, Chen YQ, Zhu Sl. | mSystems | 10.1128/msystems.00573-23 | 2023 | ||
| Akkermansia muciniphila induces slow extramedullary hematopoiesis via cooperative IL-1R/TLR signals. | Wang Y, Morishima T, Sezaki M, Sato R, Nakato G, Fukuda S, Kobiyama K, Ishii KJ, Li Y, Takizawa H. | EMBO Rep | 10.15252/embr.202357485 | 2023 | ||
| Metabolism | Substrate specificity of the galactokinase from the human gut symbiont Akkermansia muciniphila ATCC BAA-835. | Zhang X, Sheng W, Li K, Rong Y, Wu Q, Meng Q, Kong Y, Chen M. | Enzyme Microb Technol | 10.1016/j.enzmictec.2020.109568 | 2020 | |
| Potential Effects of Akkermansia Muciniphila in Aging and Aging-Related Diseases: Current Evidence and Perspectives. | Zeng SY, Liu YF, Liu JH, Zeng ZL, Xie H, Liu JH. | Aging Dis | 10.14336/ad.2023.0325 | 2023 | ||
| The evolution and competitive strategies of Akkermansia muciniphila in gut. | Kim JS, Kang SW, Lee JH, Park SH, Lee JS. | Gut Microbes | 10.1080/19490976.2021.2025017 | 2022 | ||
| Akkermansia muciniphila alleviates high-fat-diet-related metabolic-associated fatty liver disease by modulating gut microbiota and bile acids. | Wu W, Kaicen W, Bian X, Yang L, Ding S, Li Y, Li S, Zhuge A, Li L. | Microb Biotechnol | 10.1111/1751-7915.14293 | 2023 | ||
| Akkermansia muciniphila-derived acetate activates the hepatic AMPK/SIRT1/PGC-1alpha axis to alleviate ferroptosis in metabolic-associated fatty liver disease. | Zhuge A, Li S, Han S, Yuan Y, Shen J, Wu W, Wang K, Xia J, Wang Q, Gu Y, Chen E, Li L. | Acta Pharm Sin B | 10.1016/j.apsb.2024.10.010 | 2025 | ||
| The combination of Clostridium butyricum and Akkermansia muciniphila mitigates DSS-induced colitis and attenuates colitis-associated tumorigenesis by modulating gut microbiota and reducing CD8+ T cells in mice. | Hua D, Yang Q, Li X, Zhou X, Kang Y, Zhao Y, Wu D, Zhang Z, Li B, Wang X, Qi X, Chen Z, Cui G, Hong W. | mSystems | 10.1128/msystems.01567-24 | 2025 | ||
| Pathogenicity | Development of the Gut Microbial Immune and Epithelial Cellular System (GutMICS) to Investigate the Immunological Role of Gut Anaerobes. | Kwon SY, Jo SH, Park J, Park JH, Kim YR, Baek JH, Kim MG, Choi BG, Hong NY, Jung HK, Ryu HW, Jeon JS, Kim YG. | Biotechnol Bioeng | 10.1002/bit.29031 | 2025 | |
| Metabolism | Citrus Pectin Supplementation Alleviated Hepatic Lipid Accumulation through Gut Microbiota Indole Lactic Acid Promoting Hepatic Bile Acid Synthesis and Excretion. | Pan Z, Jin X, Li Q, Zhou Y, Zeng Y, Wang X, Jin Y, Chen Y, Li D, Ling W. | Int J Biol Sci | 10.7150/ijbs.116929 | 2025 | |
| Akkermansia muciniphila isolated from forest musk deer ameliorates diarrhea in mice via modification of gut microbiota. | Deng Y, Wang Y, Liu Y, Yang X, Zhang H, Xue X, Wan Y. | Animal Model Exp Med | 10.1002/ame2.12441 | 2025 | ||
| Akkermansia muciniphila supplementation prevents cognitive impairment in sleep-deprived mice by modulating microglial engulfment of synapses. | Li N, Tan S, Wang Y, Deng J, Wang N, Zhu S, Tian W, Xu J, Wang Q. | Gut Microbes | 10.1080/19490976.2023.2252764 | 2023 | ||
| Metabolism | Gut Microbiota Dysbiosis and Its Impact on Type 2 Diabetes: From Pathogenesis to Therapeutic Strategies. | Yu Y, Ding Y, Wang S, Jiang L. | Metabolites | 10.3390/metabo15060397 | 2025 | |
| Pathogenicity | Akkermansia muciniphila participates in the host protection against helminth-induced cardiac fibrosis via TLR2. | Wang J, Liu X, Sun R, Mao H, Liu M, Jin X. | PLoS Pathog | 10.1371/journal.ppat.1011683 | 2023 | |
| Pathogenicity | Akkermansia muciniphila Is Beneficial to a Mouse Model of Parkinson's Disease, via Alleviated Neuroinflammation and Promoted Neurogenesis, with Involvement of SCFAs. | Qiao CM, Huang WY, Zhou Y, Quan W, Niu GY, Li T, Zhang MX, Wu J, Zhao LP, Zhao WJ, Cui C, Shen YQ. | Brain Sci | 10.3390/brainsci14030238 | 2024 | |
| Influence of Symbiotic Fermentation Broth on Regulating Metabolism with Gut Microbiota and Metabolite Profiles Is Estimated Using a Third-Generation Sequencing Platform. | Wu CY, Huang CK, Hong WS, Liu YH, Shih MC, Lin JC. | Metabolites | 10.3390/metabo13090999 | 2023 | ||
| The Role of the Gut Microbiome and Microbial Dysbiosis in Common Skin Diseases. | Rygula I, Pikiewicz W, Grabarek BO, Wojcik M, Kaminiow K. | Int J Mol Sci | 10.3390/ijms25041984 | 2024 | ||
| Akkermansia muciniphila Ameliorates Alcoholic Liver Disease in Experimental Mice by Regulating Serum Metabolism and Improving Gut Dysbiosis. | Fang C, Cheng J, Jia W, Xu Y. | Metabolites | 10.3390/metabo13101057 | 2023 | ||
| Akkermansia muciniphila identified as key strain to alleviate gut barrier injury through Wnt signaling pathway. | Ma X, Li M, Zhang Y, Xu T, Zhou X, Qian M, Yang Z, Han X. | Elife | 10.7554/elife.92906 | 2025 | ||
| Proteome | Revealing Glycosylation Patterns in In Vitro-Produced Mucus Exposed to Pasteurized Mucus-Associated Intestinal Microbes by MALDI-TOF-MS and PGC-LC-MS/MS. | de Ram C, van der Lugt B, Elzinga J, Geerlings S, Steegenga WT, Belzer C, Schols HA. | J Agric Food Chem | 10.1021/acs.jafc.4c01401 | 2024 | |
| Akkermansia muciniphila suppressing nonalcoholic steatohepatitis associated tumorigenesis through CXCR6+ natural killer T cells. | Li T, Lin X, Shen B, Zhang W, Liu Y, Liu H, Wang Y, Zheng L, Zhi F. | Front Immunol | 10.3389/fimmu.2022.1047570 | 2022 | ||
| Effect of Extracelluar Vesicles Derived from Akkermansia muciniphila on Intestinal Barrier in Colitis Mice. | Zheng T, Hao H, Liu Q, Li J, Yao Y, Liu Y, Zhang T, Zhang Z, Yi H. | Nutrients | 10.3390/nu15224722 | 2023 | ||
| Characterizing the mucin-degrading capacity of the human gut microbiota. | Glover JS, Ticer TD, Engevik MA. | Sci Rep | 10.1038/s41598-022-11819-z | 2022 | ||
| Pathogenicity | Abelmoschus manihot polysaccharide fortifies intestinal mucus barrier to alleviate intestinal inflammation by modulating Akkermansia muciniphila abundance. | Wang Y, Li C, Li J, Zhang S, Zhang Q, Duan J, Guo J. | Acta Pharm Sin B | 10.1016/j.apsb.2024.06.002 | 2024 | |
| Dietary palmitoleic acid reprograms gut microbiota and improves biological therapy against colitis. | Chen Y, Mai Q, Chen Z, Lin T, Cai Y, Han J, Wang Y, Zhang M, Tan S, Wu Z, Chen L, Zhang Z, Yang Y, Cui T, Ouyang B, Sun Y, Yang L, Xu L, Zhang S, Li J, Shen H, Liu L, Zeng L, Zhang S, Zeng G. | Gut Microbes | 10.1080/19490976.2023.2211501 | 2023 | ||
| Potential of Akkermansia muciniphila and its outer membrane proteins as therapeutic targets for neuropsychological diseases. | Zhang F, Wang D. | Front Microbiol | 10.3389/fmicb.2023.1191445 | 2023 | ||
| Novel Candidate Microorganisms for Fermentation Technology: From Potential Benefits to Safety Issues. | Agagunduz D, Yilmaz B, Kocak T, Altintas Basar HB, Rocha JM, Ozogul F. | Foods | 10.3390/foods11193074 | 2022 | ||
| Pathogenicity | The influence of Akkermansia muciniphila on intestinal barrier function. | Mo C, Lou X, Xue J, Shi Z, Zhao Y, Wang F, Chen G. | Gut Pathog | 10.1186/s13099-024-00635-7 | 2024 | |
| Genetics | Comparative Genomics and Pan-Genome Driven Prediction of a Reduced Genome of Akkermansia muciniphila. | Bukhari SAR, Irfan M, Ahmad I, Chen L. | Microorganisms | 10.3390/microorganisms10071350 | 2022 | |
| Improvement in Zebrafish with Diabetes and Alzheimer's Disease Treated with Pasteurized Akkermansia muciniphila. | Qu L, Liu F, Fang Y, Wang L, Chen H, Yang Q, Dong H, Jin L, Wu W, Sun D. | Microbiol Spectr | 10.1128/spectrum.00849-23 | 2023 | ||
| Metabolism | Akkermansia muciniphila Cell-Free Supernatant Improves Glucose and Lipid Metabolisms in Caenorhabditis elegans. | Wu ZQ, Chen XM, Ma HQ, Li K, Wang YL, Li ZJ. | Nutrients | 10.3390/nu15071725 | 2023 | |
| Pathogenicity | Akkermansia muciniphila: A promising probiotic against inflammation and metabolic disorders. | Zhao Y, Yang H, Wu P, Yang S, Xue W, Xu B, Zhang S, Tang B, Xu D. | Virulence | 10.1080/21505594.2024.2375555 | 2024 | |
| Identification and Characterization of a Novel Species of Genus Akkermansia with Metabolic Health Effects in a Diet-Induced Obesity Mouse Model. | Kumar R, Kane H, Wang Q, Hibberd A, Jensen HM, Kim HS, Bak SY, Auzanneau I, Bry S, Christensen N, Friedman A, Rasinkangas P, Ouwehand AC, Forssten SD, Hasselwander O. | Cells | 10.3390/cells11132084 | 2022 | ||
| Metabolism | The Intestinal Effect of Atorvastatin: Akkermansia muciniphila and Barrier Function. | Cheng T, Li C, Shen L, Wang S, Li X, Fu C, Li T, Liu B, Gu Y, Wang W, Feng B. | Front Microbiol | 10.3389/fmicb.2021.797062 | 2021 | |
| The role of Akkermansia muciniphila in inflammatory bowel disease: Current knowledge and perspectives. | Zheng M, Han R, Yuan Y, Xing Y, Zhang W, Sun Z, Liu Y, Li J, Mao T. | Front Immunol | 10.3389/fimmu.2022.1089600 | 2022 | ||
| Membrane Protein Amuc_1100 Derived from Akkermansia muciniphila Facilitates Lipolysis and Browning via Activating the AC3/PKA/HSL Pathway. | Zheng X, Huang W, Li Q, Chen Y, Wu L, Dong Y, Huang X, He X, Ou Z, Peng Y. | Microbiol Spectr | 10.1128/spectrum.04323-22 | 2023 | ||
| Pathogenicity | The lipooligosaccharide of the gut symbiont Akkermansia muciniphila exhibits a remarkable structure and TLR signaling capacity. | Garcia-Vello P, Tytgat HLP, Elzinga J, Van Hul M, Plovier H, Tiemblo-Martin M, Cani PD, Nicolardi S, Fragai M, De Castro C, Di Lorenzo F, Silipo A, Molinaro A, de Vos WM. | Nat Commun | 10.1038/s41467-024-52683-x | 2024 | |
| Binding of Akkermansia muciniphila to mucin is O-glycan specific. | Elzinga J, Narimatsu Y, de Haan N, Clausen H, de Vos WM, Tytgat HLP. | Nat Commun | 10.1038/s41467-024-48770-8 | 2024 | ||
| Analysis of Akkermansia muciniphila in Mulberry Galacto-Oligosaccharide Medium via Comparative Transcriptomics. | Li E, Li S, Liu F, Li Q, Pang D, Wang H, Liao S, Zou Y. | Foods | 10.3390/foods12030440 | 2023 | ||
| Akkermansia muciniphila and Lactobacillus plantarum ameliorate systemic lupus erythematosus by possibly regulating immune response and remodeling gut microbiota. | Guo M, Lu M, Chen K, Xu R, Xia Y, Liu X, Liu Z, Liu Q. | mSphere | 10.1128/msphere.00070-23 | 2023 | ||
| Quantitative real-time PCR analysis of bacterial biomarkers enable fast and accurate monitoring in inflammatory bowel disease. | Sezgin E, Terlemez G, Bozkurt B, Bengi G, Akpinar H, Buyuktorun I. | PeerJ | 10.7717/peerj.14217 | 2022 | ||
| Akkermansia muciniphila exerts immunomodulatory and anti-inflammatory effects on gliadin-stimulated THP-1 derived macrophages. | Molaaghaee-Rouzbahani S, Asri N, Sapone A, Baghaei K, Yadegar A, Amani D, Rostami-Nejad M. | Sci Rep | 10.1038/s41598-023-30266-y | 2023 | ||
| Extracellular vesicles hybrid plasmid-loaded lipid nanovesicles for synergistic cancer immunotherapy. | Tong Q, Li K, Huang F, Dai Y, Zhang T, Muaibati M, Abuduyilimu A, Huang X. | Mater Today Bio | 10.1016/j.mtbio.2023.100845 | 2023 | ||
| Enzymology | Division of the large and multifunctional glycoside hydrolase family 2: high functional specificity and biochemical assays in the uncharacterized subfamilies. | Lebreton A, Garron ML, Vuillemin M, Pilgaard B, Hornung BVH, Drula E, Lombard V, Helbert W, Henrissat B, Terrapon N. | Biotechnol Biofuels Bioprod | 10.1186/s13068-025-02669-8 | 2025 | |
| Characterization of three novel beta-galactosidases from Akkermansia muciniphila involved in mucin degradation. | Kosciow K, Deppenmeier U. | Int J Biol Macromol | 10.1016/j.ijbiomac.2020.01.246 | 2020 | ||
| Phylogeny | Outlook on next-generation probiotics from the human gut. | De Filippis F, Esposito A, Ercolini D. | Cell Mol Life Sci | 10.1007/s00018-021-04080-6 | 2022 | |
| Phylogeny | An Akkermansia muciniphila subtype alleviates high-fat diet-induced metabolic disorders and inhibits the neurodegenerative process in mice. | Wu F, Guo X, Zhang M, Ou Z, Wu D, Deng L, Lu Z, Zhang J, Deng G, Chen S, Li S, Yi J, Peng Y. | Anaerobe | 10.1016/j.anaerobe.2019.102138 | 2020 | |
| Lactobacillus paragasseri OLL2809 Improves Depression-Like Behavior and Increases Beneficial Gut Microbes in Mice. | Hashikawa-Hobara N, Otsuka A, Okujima C, Hashikawa N. | Front Neurosci | 10.3389/fnins.2022.918953 | 2022 | ||
| Biomimetic superabsorbent hydrogel acts as a gut protective dynamic exoskeleton improving metabolic parameters and expanding A. muciniphila. | Silvestri A, Gil-Gomez A, Vitale M, Braga D, Demitri C, Brescia P, Madaghiele M, Spadoni I, Jones B, Fornasa G, Mouries J, Carloni S, Lizier M, Romero-Gomez M, Penna G, Sannino A, Rescigno M. | Cell Rep Med | 10.1016/j.xcrm.2023.101235 | 2023 | ||
| Gut Microbiota and B Cell Receptor (BCR) Inhibitors for the Treatment of Chronic Lymphocytic Leukemia: Is Biodiversity Correlated with Clinical Response or Immune-Related Adverse Event Occurrence? A Cross-Sectional Study. | Zuccaro V, Petazzoni G, Mileto I, Corbella M, Asperges E, Sacchi P, Rattotti S, Varettoni M, Defrancesco I, Cambieri P, Baldanti F, Arcaini L, Bruno R. | Microorganisms | 10.3390/microorganisms11051305 | 2023 | ||
| Pathogenicity | Akkermansia muciniphila Alleviates Persistent Inflammation, Immunosuppression, and Catabolism Syndrome in Mice. | Xu Y, Duan J, Wang D, Liu J, Chen X, Qin XY, Yu W. | Metabolites | 10.3390/metabo13020194 | 2023 | |
| Extracellular Vesicles of Probiotics: Shedding Light on the Biological Activity and Future Applications. | Krzyzek P, Marinacci B, Vitale I, Grande R. | Pharmaceutics | 10.3390/pharmaceutics15020522 | 2023 | ||
| Interspecies commensal interactions have nonlinear impacts on host immunity. | Rice TA, Bielecka AA, Nguyen MT, Rosen CE, Song D, Sonnert ND, Yang Y, Cao Y, Khetrapal V, Catanzaro JR, Martin AL, Rashed SA, Leopold SR, Hao L, Yu X, van Dijk D, Ring AM, Flavell RA, de Zoete MR, Palm NW. | Cell Host Microbe | 10.1016/j.chom.2022.05.004 | 2022 | ||
| Zonated Copper-Driven Breast Cancer Progression Countered by a Copper-Depleting Nanoagent for Immune and Metabolic Reprogramming. | Chen L, Ma S, Wu H, Zheng L, Yi Y, Liu G, Li B, Sun J, Du Y, Wang B, Liu Y, Zhang C, Chang J, Pang Y, Wang W, Wang M, Zhu M. | Adv Sci (Weinh) | 10.1002/advs.202412434 | 2025 | ||
| Extracellular vesicles derived from Akkermansia muciniphila promote placentation and mitigate preeclampsia in a mouse model. | Chen Y, Ou Z, Pang M, Tao Z, Zheng X, Huang Z, Wen D, Li Q, Zhou R, Chen P, Situ B, Sheng C, Huang Y, Yue X, Zheng L, Huang L. | J Extracell Vesicles | 10.1002/jev2.12328 | 2023 | ||
| Corrigendum: Akkermansia muciniphila as a Model Case for the Development of an Improved Quantitative RPA Microbiome Assay. | Goux HJ, Chavan D, Crum M, Kourentzi K, Willson RC. | Front Cell Infect Microbiol | 10.3389/fcimb.2019.00032 | 2019 | ||
| Microbiome and cancer: from mechanistic implications in disease progression and treatment to development of novel antitumoral strategies. | Constantin M, Chifiriuc MC, Mihaescu G, Corcionivoschi N, Burlibasa L, Bleotu C, Tudorache S, Mitache MM, Filip R, Munteanu SG, Gradisteanu Pircalabioru G. | Front Immunol | 10.3389/fimmu.2024.1373504 | 2024 | ||
| Data-driven prediction of colonization outcomes for complex microbial communities. | Wu L, Wang XW, Tao Z, Wang T, Zuo W, Zeng Y, Liu YY, Dai L. | Nat Commun | 10.1038/s41467-024-46766-y | 2024 | ||
| Role of bacteria in cancers and their therapeutic potential: Review of current knowledge. | Wawrety W, Kedziora A. | Iran J Basic Med Sci | 10.22038/ijbms.2024.77667.16798 | 2025 | ||
| Metabolism | Akkermansia muciniphila Enhances Egg Quality and the Lipid Profile of Egg Yolk by Improving Lipid Metabolism. | Wei F, Yang X, Zhang M, Xu C, Hu Y, Liu D. | Front Microbiol | 10.3389/fmicb.2022.927245 | 2022 | |
| Polydopamine/chitosan layer-by-layer coating of Bacillus cereus enhances the robustness of live anti-oxidation materials for the treatment of radiation enteritis | Zhang F, Zeng L, Zuo J, Tan Y, Wang K, Li Z, Su Y, Hu Y, Chen Z, Hong J, Du L, Jin Y, Yuan B. | Mater Today Bio | 2025 | |||
| Oral administration of Faecalibacterium prausnitzii and Akkermansia muciniphila strains from humans improves atopic dermatitis symptoms in DNCB induced NC/Nga mice. | Lee Y, Byeon HR, Jang SY, Hong MG, Kim D, Lee D, Shin JH, Kim Y, Kang SG, Seo JG. | Sci Rep | 10.1038/s41598-022-11048-4 | 2022 | ||
| Pathogenicity | GLP-1RAs attenuated obesity and reversed leptin resistance partly via activating the microbiome-derived inosine/A2A pathway. | Dong C, Zhou B, Zhao B, Lin K, Tian Y, Zhang R, Xie D, Wu S, Yang L. | Acta Pharm Sin B | 10.1016/j.apsb.2024.12.006 | 2025 | |
| Genetics | A thousand metagenome-assembled genomes of Akkermansia reveal phylogroups and geographical and functional variations in the human gut. | Lv QB, Li S, Zhang Y, Guo R, Wang YC, Peng Y, Zhang XX. | Front Cell Infect Microbiol | 10.3389/fcimb.2022.957439 | 2022 | |
| Akkermansia muciniphila and Faecalibacterium prausnitzii in Immune-Related Diseases. | Effendi RMRA, Anshory M, Kalim H, Dwiyana RF, Suwarsa O, Pardo LM, Nijsten TEC, Thio HB. | Microorganisms | 10.3390/microorganisms10122382 | 2022 | ||
| Correlating the Gut Microbiota and Circulating Hormones with Acne Lesion Counts and Skin Biophysical Features. | Sivamani RK, Maloh J, Nong Y. | Microorganisms | 10.3390/microorganisms11082049 | 2023 | ||
| Pathogenicity | The Use of Microbial Modifying Therapies to Prevent Psoriasis Exacerbation and Associated Cardiovascular Comorbidity. | Reali E, Caliceti C, Lorenzini A, Rizzo P. | Inflammation | 10.1007/s10753-023-01915-1 | 2024 | |
| Turning universal O into rare Bombay type blood. | Anso I, Naegeli A, Cifuente JO, Orrantia A, Andersson E, Zenarruzabeitia O, Moraleda-Montoya A, Garcia-Alija M, Corzana F, Del Orbe RA, Borrego F, Trastoy B, Sjogren J, Guerin ME. | Nat Commun | 10.1038/s41467-023-37324-z | 2023 | ||
| Enzymology | Strain-Specific Anti-inflammatory Properties of Two Akkermansia muciniphila Strains on Chronic Colitis in Mice. | Zhai R, Xue X, Zhang L, Yang X, Zhao L, Zhang C. | Front Cell Infect Microbiol | 10.3389/fcimb.2019.00239 | 2019 | |
| Safety of pasteurised Akkermansia muciniphila as a novel food pursuant to Regulation (EU) 2015/2283. | EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Turck D, Bohn T, Castenmiller J, De Henauw S, Hirsch-Ernst KI, Maciuk A, Mangelsdorf I, McArdle HJ, Naska A, Pelaez C, Pentieva K, Siani A, Thies F, Tsabouri S, Vinceti M, Cubadda F, Frenzel T, Heinonen M, Marchelli R, Neuhauser-Berthold M, Poulsen M, Prieto Maradona M, Schlatter JR, van Loveren H, Ackerl R, Knutsen HK. | EFSA J | 10.2903/j.efsa.2021.6780 | 2021 | ||
| Dietary Boswellia serrata Acid Alters the Gut Microbiome and Blood Metabolites in Experimental Models. | Suther C, Daddi L, Bokoliya S, Panier H, Liu Z, Lin Q, Han Y, Chen K, Moore MD, Zhou Y. | Nutrients | 10.3390/nu14040814 | 2022 | ||
| Experimental evaluation of ecological principles to understand and modulate the outcome of bacterial strain competition in gut microbiomes. | Segura Munoz RR, Mantz S, Martinez I, Li F, Schmaltz RJ, Pudlo NA, Urs K, Martens EC, Walter J, Ramer-Tait AE. | ISME J | 10.1038/s41396-022-01208-9 | 2022 | ||
| Metabolism | Pasteurized Akkermansia muciniphila Reduces Fat Accumulation via nhr-49-Mediated Nuclear Hormone Signaling Pathway in Caenorhabditis elegans. | Wu Z, Xiao Y, Zhou F, Chen J, Chen X, Hou A, Wang Y, Li Z. | Molecules | 10.3390/molecules27196159 | 2022 | |
| Metabolism | Microbiome and spatially resolved metabolomics analysis reveal the anticancer role of gut Akkermansia muciniphila by crosstalk with intratumoral microbiota and reprogramming tumoral metabolism in mice. | Zhu Z, Cai J, Hou W, Xu K, Wu X, Song Y, Bai C, Mo YY, Zhang Z. | Gut Microbes | 10.1080/19490976.2023.2166700 | 2023 | |
| Pathogenicity | Microbial and host factors contribute to bloodstream infection in a pediatric acute lymphocytic leukemia mouse model. | Song Y, Perlman K, Gyarmati P. | Heliyon | 10.1016/j.heliyon.2022.e11340 | 2022 | |
| Stronger gut microbiome modulatory effects by postbiotics than probiotics in a mouse colitis model. | Zhang T, Zhang W, Feng C, Kwok LY, He Q, Sun Z. | NPJ Sci Food | 10.1038/s41538-022-00169-9 | 2022 | ||
| Effects of Akkermansia muciniphila and Faecalibacterium prausnitzii on serotonin transporter expression in intestinal epithelial cells. | Yaghoubfar R, Behrouzi A, Fateh A, Nojoumi SA, Vaziri F, Khatami S, Siadat SD. | J Diabetes Metab Disord | 10.1007/s40200-020-00539-8 | 2021 | ||
| Probiotics and postbiotics in colorectal cancer: Prevention and complementary therapy. | Kvakova M, Kamlarova A, Stofilova J, Benetinova V, Bertkova I. | World J Gastroenterol | 10.3748/wjg.v28.i27.3370 | 2022 | ||
| Akkermansia muciniphila administration exacerbated the development of colitis-associated colorectal cancer in mice. | Wang F, Cai K, Xiao Q, He L, Xie L, Liu Z. | J Cancer | 10.7150/jca.63578 | 2022 | ||
| Native and Engineered Probiotics: Promising Agents against Related Systemic and Intestinal Diseases. | Shen H, Zhao Z, Zhao Z, Chen Y, Zhang L. | Int J Mol Sci | 10.3390/ijms23020594 | 2022 | ||
| The Concept of Postbiotics. | Vinderola G, Sanders ME, Salminen S. | Foods | 10.3390/foods11081077 | 2022 | ||
| Interrelated Effects of Zinc Deficiency and the Microbiome on Group B Streptococcal Vaginal Colonization. | Burcham LR, Burcham ZM, Akbari MS, Metcalf JL, Doran KS. | mSphere | 10.1128/msphere.00264-22 | 2022 | ||
| The identification of metabolites from gut microbiota in NAFLD via network pharmacology. | Oh KK, Gupta H, Min BH, Ganesan R, Sharma SP, Won SM, Jeong JJ, Lee SB, Cha MG, Kwon GH, Jeong MK, Hyun JY, Eom JA, Park HJ, Yoon SJ, Choi MR, Kim DJ, Suk KT. | Sci Rep | 10.1038/s41598-023-27885-w | 2023 | ||
| Effects of active, inactive, and derivatives of Akkermansia muciniphila on the expression of the endocannabinoid system and PPARs genes. | Ghaderi F, Sotoodehnejadnematalahi F, Hajebrahimi Z, Fateh A, Siadat SD. | Sci Rep | 10.1038/s41598-022-13840-8 | 2022 | ||
| Fucose promotes intestinal stem cell-mediated intestinal epithelial development through promoting Akkermansia-related propanoate metabolism. | Duan C, Wu J, Wang Z, Tan C, Hou L, Qian W, Han C, Hou X. | Gut Microbes | 10.1080/19490976.2023.2233149 | 2023 | ||
| Akkermansia Muciniphila Potentiates the Antitumor Efficacy of FOLFOX in Colon Cancer. | Hou X, Zhang P, Du H, Chu W, Sun R, Qin S, Tian Y, Zhang Z, Xu F. | Front Pharmacol | 10.3389/fphar.2021.725583 | 2021 | ||
| Metabolism | Structural basis of mammalian mucin processing by the human gut O-glycopeptidase OgpA from Akkermansia muciniphila. | Trastoy B, Naegeli A, Anso I, Sjogren J, Guerin ME. | Nat Commun | 10.1038/s41467-020-18696-y | 2020 | |
| Enzymology | Akkermansia muciniphila as a Model Case for the Development of an Improved Quantitative RPA Microbiome Assay. | Goux HJ, Chavan D, Crum M, Kourentzi K, Willson RC. | Front Cell Infect Microbiol | 10.3389/fcimb.2018.00237 | 2018 | |
| The Interplay of Dietary Fibers and Intestinal Microbiota Affects Type 2 Diabetes by Generating Short-Chain Fatty Acids. | Mazhar M, Zhu Y, Qin L. | Foods | 10.3390/foods12051023 | 2023 | ||
| Genetics | Comparative genomic and functional analysis of Akkermansia muciniphila and closely related species. | Xing J, Li X, Sun Y, Zhao J, Miao S, Xiong Q, Zhang Y, Zhang G. | Genes Genomics | 10.1007/s13258-019-00855-1 | 2019 | |
| Akkermansia muciniphila Colonization Alleviating High Fructose and Restraint Stress-Induced Jejunal Mucosal Barrier Disruption. | Yu J, Liu T, Gao Z, Liu R, Wang Z, Chen Y, Cao J, Dong Y. | Nutrients | 10.3390/nu14153164 | 2022 | ||
| Engineered Akkermansia muciniphila: A promising agent against diseases (Review). | Zou Y, Chen T. | Exp Ther Med | 10.3892/etm.2020.9415 | 2020 | ||
| Enriched pathways in gut microbiome predict response to immune checkpoint inhibitor treatment across demographic regions and various cancer types. | Cai X, Cho JY, Chen L, Liu Y, Ji F, Salgado K, Ge S, Yang D, Yu H, Shao J, Futreal PA, Sepesi B, Gibbons D, Chen Y, Wang G, Cheng C, Wu M, Zhang J, Hsiao A, Xia T. | iScience | 10.1016/j.isci.2025.112162 | 2025 | ||
| Gut Microbiota-Derived 3-Hydroxybutyrate Blocks GPR43-Mediated IL6 Signaling to Ameliorate Radiation Proctopathy. | Ge Z, Chen C, Chen J, Jiang Z, Chen L, Wei Y, Chen H, He L, Zou Y, Long X, Zhan H, Wang H, Wang H, Lu Y. | Adv Sci (Weinh) | 10.1002/advs.202306217 | 2024 | ||
| Social Hierarchy Dictates Intestinal Radiation Injury in a Gut Microbiota-Dependent Manner. | Zeng X, Liu Z, Dong Y, Zhao J, Wang B, Xiao H, Li Y, Chen Z, Liu X, Liu J, Dong J, Fan S, Cui M. | Int J Mol Sci | 10.3390/ijms232113189 | 2022 | ||
| Pathogenicity | Akkermansia muciniphila strain ATCC BAA-835 does not promote short-term intestinal inflammation in gnotobiotic interleukin-10-deficient mice. | Ring C, Klopfleisch R, Dahlke K, Basic M, Bleich A, Blaut M. | Gut Microbes | 10.1080/19490976.2018.1511663 | 2019 | |
| Genetics | Genomic Evidence for Bacterial Determinants Influencing Obesity Development. | Isokpehi RD, Simmons SS, Johnson MO, Payton M. | Int J Environ Res Public Health | 10.3390/ijerph14040345 | 2017 | |
| Crystal structure of monomeric Amuc_1100 from Akkermansia muciniphila. | Mou L, Peng X, Chen Y, Xiao Q, Liao H, Liu M, Guo L, Liu Y, Zhang X, Deng D. | Acta Crystallogr F Struct Biol Commun | 10.1107/s2053230x20004124 | 2020 | ||
| Pathogenicity | The biological activity and potential of probiotics-derived extracellular vesicles as postbiotics in modulating microbiota-host communication. | Zhang X, Wang Y, E Q, Naveed M, Wang X, Liu Y, Li M. | J Nanobiotechnology | 10.1186/s12951-025-03435-6 | 2025 | |
| Metabolism | Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis. | Rao Y, Kuang Z, Li C, Guo S, Xu Y, Zhao D, Hu Y, Song B, Jiang Z, Ge Z, Liu X, Li C, Chen S, Ye J, Huang Z, Lu Y. | Gut Microbes | 10.1080/19490976.2021.1927633 | 2021 | |
| Study of growth, metabolism, and morphology of Akkermansia muciniphila with an in vitro advanced bionic intestinal reactor. | Li Z, Hu G, Zhu L, Sun Z, Jiang Y, Gao MJ, Zhan X. | BMC Microbiol | 10.1186/s12866-021-02111-7 | 2021 | ||
| Genetics | Genome sequencing of 39 Akkermansia muciniphila isolates reveals its population structure, genomic and functional diverisity, and global distribution in mammalian gut microbiotas. | Guo X, Li S, Zhang J, Wu F, Li X, Wu D, Zhang M, Ou Z, Jie Z, Yan Q, Li P, Yi J, Peng Y. | BMC Genomics | 10.1186/s12864-017-4195-3 | 2017 | |
| A novel peptide protects against diet-induced obesity by suppressing appetite and modulating the gut microbiota. | Li Z, Zhang B, Wang N, Zuo Z, Wei H, Zhao F. | Gut | 10.1136/gutjnl-2022-328035 | 2023 | ||
| A Continuous Battle for Host-Derived Glycans Between a Mucus Specialist and a Glycan Generalist in vitro and in vivo. | Kostopoulos I, Aalvink S, Kovatcheva-Datchary P, Nijsse B, Backhed F, Knol J, de Vos WM, Belzer C. | Front Microbiol | 10.3389/fmicb.2021.632454 | 2021 | ||
| Genetics | Genome-wide multi-omics analysis reveals the nutrient-dependent metabolic features of mucin-degrading gut bacteria. | Kim KS, Tiffany E, Lee JY, Oh A, Jin HS, Kim JS, Lee JS, Nam MH, Hong SJ, Park S, Koh H, Kim BS, Lee YK, Lee DW. | Gut Microbes | 10.1080/19490976.2023.2221811 | 2023 | |
| Enzymology | Structure and function of microbial alpha-l-fucosidases: a mini review. | Wu H, Owen CD, Juge N. | Essays Biochem | 10.1042/ebc20220158 | 2023 | |
| Health and Disease: Akkermansia muciniphila, the Shining Star of the Gut Flora. | Xue C, Li G, Gu X, Su Y, Zheng Q, Yuan X, Bao Z, Lu J, Li L. | Research (Wash D C) | 10.34133/research.0107 | 2023 | ||
| Pathogenicity | Akkermansia muciniphila and Its Pili-Like Protein Amuc_1100 Modulate Macrophage Polarization in Experimental Periodontitis. | Mulhall H, DiChiara JM, Deragon M, Iyer R, Huck O, Amar S. | Infect Immun | 10.1128/iai.00500-20 | 2020 | |
| Arylsulfamates inhibit colonic Bacteroidota growth through a sulfatase-independent mechanism. | Crawford CJ, Tomlinson CWE, Gunawan C, Chen Z, Byrne DP, Darby C, Conti MLG, Larson T, Luis AS, Elli S, Yates EA, Bolam DN, van der Post S, Williams SJ, Cartmell A. | Proc Natl Acad Sci U S A | 10.1073/pnas.2414331122 | 2025 | ||
| Loureirin A is a narrow-spectrum antimicrobial agent against Helicobacter pylori. | Tong Q, Yin C, Hang X, Bai Y, Zhang C, Xu J, Huang Y, Ge Y, Chen T, Zeng L, Jia J, Bi H. | Antimicrob Agents Chemother | 10.1128/aac.00314-24 | 2024 | ||
| Identification of Gut Microbiome Metabolites via Network Pharmacology Analysis in Treating Alcoholic Liver Disease. | Oh KK, Choi YR, Gupta H, Ganesan R, Sharma SP, Won SM, Jeong JJ, Lee SB, Cha MG, Kwon GH, Kim DJ, Suk KT. | Curr Issues Mol Biol | 10.3390/cimb44070224 | 2022 | ||
| Metabolism | Characterization of a phospholipid-regulated beta-galactosidase from Akkermansia muciniphila involved in mucin degradation. | Kosciow K, Deppenmeier U. | Microbiologyopen | 10.1002/mbo3.796 | 2019 | |
| The Protective Effects of Live and Pasteurized Akkermansia muciniphila and Its Extracellular Vesicles against HFD/CCl4-Induced Liver Injury. | Keshavarz Azizi Raftar S, Ashrafian F, Yadegar A, Lari A, Moradi HR, Shahriary A, Azimirad M, Alavifard H, Mohsenifar Z, Davari M, Vaziri F, Moshiri A, Siadat SD, Zali MR. | Microbiol Spectr | 10.1128/spectrum.00484-21 | 2021 | ||
| Anti-obesity Effect of Capsaicin in Mice Fed with High-Fat Diet Is Associated with an Increase in Population of the Gut Bacterium Akkermansia muciniphila. | Shen W, Shen M, Zhao X, Zhu H, Yang Y, Lu S, Tan Y, Li G, Li M, Wang J, Hu F, Le S. | Front Microbiol | 10.3389/fmicb.2017.00272 | 2017 | ||
| Metabolism | A Purified Aspartic Protease from Akkermansia Muciniphila Plays an Important Role in Degrading Muc2. | Meng X, Wang W, Lan T, Yang W, Yu D, Fang X, Wu H. | Int J Mol Sci | 10.3390/ijms21010072 | 2019 | |
| Oral Supplementation of Lead-Intolerant Intestinal Microbes Protects Against Lead (Pb) Toxicity in Mice. | Zhai Q, Qu D, Feng S, Yu Y, Yu L, Tian F, Zhao J, Zhang H, Chen W. | Front Microbiol | 10.3389/fmicb.2019.03161 | 2019 | ||
| Beneficial Effects of Newly Isolated Akkermansia muciniphila Strains from the Human Gut on Obesity and Metabolic Dysregulation. | Yang M, Bose S, Lim S, Seo J, Shin J, Lee D, Chung WH, Song EJ, Nam YD, Kim H. | Microorganisms | 10.3390/microorganisms8091413 | 2020 | ||
| Pathogenicity | Low-Intensity Exercise Modulates Gut Microbiota to Fight Against Radiation-Induced Gut Toxicity in Mouse Models. | Wang B, Jin YX, Dong JL, Xiao HW, Zhang SQ, Li Y, Chen ZY, Yang XD, Fan SJ, Cui M. | Front Cell Dev Biol | 10.3389/fcell.2021.706755 | 2021 | |
| Pathogenicity | Revisiting the role of Akkermansia muciniphila as a therapeutic bacterium. | Si J, Kang H, You HJ, Ko G. | Gut Microbes | 10.1080/19490976.2022.2078619 | 2022 | |
| Gastrointestinal Dysmotility Predisposes to Colitis through Regulation of Gut Microbial Composition and Linoleic Acid Metabolism. | Zhang Y, Song F, Yang M, Chen C, Cui J, Xing M, Dai Y, Li M, Cao Y, Lu L, Zhu H, Liu Y, Ma C, Wei Q, Qin H, Li J. | Adv Sci (Weinh) | 10.1002/advs.202306297 | 2024 | ||
| Metabolism | Intestinal colonization regulates systemic anti-commensal immune sensitivity and hyperreactivity. | Burkhard R, Koegler M, Brown K, Wilson K, Mager LF, Zucoloto AZ, Thomson C, Hebbandi Nanjundappa R, Skalosky I, Ahmadi S, McDonald B, Geuking MB. | Front Immunol | 10.3389/fimmu.2023.1030395 | 2023 | |
| Enzymology | Different subtype strains of Akkermansia muciniphila abundantly colonize in southern China. | Guo X, Zhang J, Wu F, Zhang M, Yi M, Peng Y. | J Appl Microbiol | 10.1111/jam.13022 | 2016 | |
| GH20 and GH84 beta-N-acetylglucosaminidases with different linkage specificities underpin mucin O-glycan breakdown capability of Bifidobacterium bifidum. | Takada H, Katoh T, Sakanaka M, Odamaki T, Katayama T. | J Biol Chem | 10.1016/j.jbc.2023.104781 | 2023 | ||
| Antagonism Between Gut Ruminococcus gnavus and Akkermansia muciniphila Modulates the Progression of Chronic Hepatitis B. | Chua HH, Chen YH, Wu LL, Yang HC, Lin CR, Chen HL, Wu JF, Chang MH, Chen PJ, Ni YH. | Cell Mol Gastroenterol Hepatol | 10.1016/j.jcmgh.2023.12.003 | 2024 | ||
| Gut microbiome at the crossroad of genetic variants and behavior disorders. | Cheng L, Wu H, Chen Z, Hao H, Zheng X. | Gut Microbes | 10.1080/19490976.2023.2201156 | 2023 | ||
| A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8+ T cells in mice. | Wang L, Tang L, Feng Y, Zhao S, Han M, Zhang C, Yuan G, Zhu J, Cao S, Wu Q, Li L, Zhang Z. | Gut | 10.1136/gutjnl-2019-320105 | 2020 | ||
| Genetics | Microbial characterization based on multifractal analysis of metagenomes. | Xie XH, Huang YJ, Han GS, Yu ZG, Ma YL. | Front Cell Infect Microbiol | 10.3389/fcimb.2023.1117421 | 2023 | |
| Pathogenicity | Extracellular Vesicles from Akkermansia muciniphila Elicit Antitumor Immunity Against Prostate Cancer via Modulation of CD8+ T Cells and Macrophages. | Luo ZW, Xia K, Liu YW, Liu JH, Rao SS, Hu XK, Chen CY, Xu R, Wang ZX, Xie H. | Int J Nanomedicine | 10.2147/ijn.s304515 | 2021 | |
| Spinal fluid IgG antibodies from patients with demyelinating diseases bind multiple sclerosis-associated bacteria. | Eckman E, Laman JD, Fischer KF, Lopansri B, Martins TB, Hill HR, Kriesel JD. | J Mol Med (Berl) | 10.1007/s00109-021-02085-z | 2021 | ||
| Metabolism | Rationally designed bacterial consortia to treat chronic immune-mediated colitis and restore intestinal homeostasis. | van der Lelie D, Oka A, Taghavi S, Umeno J, Fan TJ, Merrell KE, Watson SD, Ouellette L, Liu B, Awoniyi M, Lai Y, Chi L, Lu K, Henry CS, Sartor RB. | Nat Commun | 10.1038/s41467-021-23460-x | 2021 | |
| Role of the gut microbiome in three major psychiatric disorders. | Borkent J, Ioannou M, Laman JD, Haarman BCM, Sommer IEC, Sommer IEC. | Psychol Med | 10.1017/s0033291722000897 | 2022 | ||
| Comparative analysis of prebiotic effects of four oligosaccharides using in vitro gut model: digestibility, microbiome, and metabolome changes. | Cheon S, Kim G, Bae JH, Lee DH, Seong H, Kim DH, Han JS, Lim SY, Han NS. | FEMS Microbiol Ecol | 10.1093/femsec/fiad002 | 2023 | ||
| Akkermansia muciniphila prevents cold-related atrial fibrillation in rats by modulation of TMAO induced cardiac pyroptosis. | Luo Y, Zhang Y, Han X, Yuan Y, Zhou Y, Gao Y, Yu H, Zhang J, Shi Y, Duan Y, Zhao X, Yan S, Hao H, Dai C, Zhao S, Shi J, Li W, Zhang S, Xu W, Fang N, Gong Y, Li Y. | EBioMedicine | 10.1016/j.ebiom.2022.104087 | 2022 | ||
| Phylogeny | Genomic diversity and ecology of human-associated Akkermansia species in the gut microbiome revealed by extensive metagenomic assembly. | Karcher N, Nigro E, Puncochar M, Blanco-Miguez A, Ciciani M, Manghi P, Zolfo M, Cumbo F, Manara S, Golzato D, Cereseto A, Arumugam M, Bui TPN, Tytgat HLP, Valles-Colomer M, de Vos WM, Segata N. | Genome Biol | 10.1186/s13059-021-02427-7 | 2021 | |
| Metabolism | Extracellular vesicles and pasteurized cells derived from Akkermansia muciniphila protect against high-fat induced obesity in mice. | Ashrafian F, Keshavarz Azizi Raftar S, Lari A, Shahryari A, Abdollahiyan S, Moradi HR, Masoumi M, Davari M, Khatami S, Omrani MD, Vaziri F, Masotti A, Siadat SD. | Microb Cell Fact | 10.1186/s12934-021-01709-w | 2021 | |
| Pathogenicity | Comparative study of effect of Akkermansia muciniphila and its extracellular vesicles on toll-like receptors and tight junction. | Ashrafian F, Behrouzi A, Shahriary A, Ahmadi Badi S, Davari M, Khatami S, Rahimi Jamnani F, Fateh A, Vaziri F, Siadat SD. | Gastroenterol Hepatol Bed Bench | 2019 | ||
| Akkermansia muciniphila Improves Host Defense Against Influenza Virus Infection. | Hu X, Zhao Y, Yang Y, Gong W, Sun X, Yang L, Zhang Q, Jin M. | Front Microbiol | 10.3389/fmicb.2020.586476 | 2020 | ||
| Disruption of the Intestinal Mucosal Barrier Induced by High Fructose and Restraint Stress Is Regulated by the Intestinal Microbiota and Microbiota Metabolites. | Yu J, Liu T, Guo Q, Wang Z, Chen Y, Dong Y. | Microbiol Spectr | 10.1128/spectrum.04698-22 | 2023 | ||
| Effects of Live and Pasteurized Forms of Akkermansia from the Human Gut on Obesity and Metabolic Dysregulation. | Choi Y, Bose S, Seo J, Shin JH, Lee D, Kim Y, Kang SG, Kim H. | Microorganisms | 10.3390/microorganisms9102039 | 2021 | ||
| Pathogenicity | Unravelling the antimicrobial action of antidepressants on gut commensal microbes. | Ait Chait Y, Mottawea W, Tompkins TA, Hammami R. | Sci Rep | 10.1038/s41598-020-74934-9 | 2020 | |
| Utilization Efficiency of Human Milk Oligosaccharides by Human-Associated Akkermansia Is Strain Dependent. | Luna E, Parkar SG, Kirmiz N, Hartel S, Hearn E, Hossine M, Kurdian A, Mendoza C, Orr K, Padilla L, Ramirez K, Salcedo P, Serrano E, Choudhury B, Paulchakrabarti M, Parker CT, Huynh S, Cooper K, Flores GE. | Appl Environ Microbiol | 10.1128/aem.01487-21 | 2022 | ||
| Pathogenicity | Structural Characterization of a Polysaccharide from Gastrodia elata and Its Bioactivity on Gut Microbiota. | Huo J, Lei M, Li F, Hou J, Zhang Z, Long H, Zhong X, Liu Y, Xie C, Wu W. | Molecules | 10.3390/molecules26154443 | 2021 | |
| Pathogenicity | Comparative effects of alive and pasteurized Akkermansia muciniphila on normal diet-fed mice. | Ashrafian F, Keshavarz Azizi Raftar S, Shahryari A, Behrouzi A, Yaghoubfar R, Lari A, Moradi HR, Khatami S, Omrani MD, Vaziri F, Masotti A, Siadat SD. | Sci Rep | 10.1038/s41598-021-95738-5 | 2021 | |
| Metabolism | Synthetic Microbiomes on the Rise-Application in Deciphering the Role of Microbes in Host Health and Disease. | Bolsega S, Bleich A, Basic M. | Nutrients | 10.3390/nu13114173 | 2021 | |
| Akkermansia muciniphila protects intestinal mucosa from damage caused by S. pullorum by initiating proliferation of intestinal epithelium. | Zhu L, Lu X, Liu L, Voglmeir J, Zhong X, Yu Q. | Vet Res | 10.1186/s13567-020-00755-3 | 2020 | ||
| Synthetic microbial consortia for the treatment of Clostridioides difficile infection in mice model. | Liu J, Zhu W, Lessing DJ, Chu W. | Microb Biotechnol | 10.1111/1751-7915.14333 | 2023 | ||
| Nucleotide binding as an allosteric regulatory mechanism for Akkermansia muciniphila beta-N-acetylhexosaminidase Am2136. | Li CC, Yi H, Wang YM, Tang XY, Zhu YB, Song YJ, Zhao NL, Huang Q, Mou XY, Luo GH, Liu TG, Yang GL, Zeng YJ, Wang LJ, Tang H, Fan G, Bao R. | Gut Microbes | 10.1080/19490976.2022.2143221 | 2022 | ||
| Phylogeny | Genome and pan-genome analysis to classify emerging bacteria. | Caputo A, Fournier PE, Raoult D. | Biol Direct | 10.1186/s13062-019-0234-0 | 2019 | |
| Function of Akkermansia muciniphila in Obesity: Interactions With Lipid Metabolism, Immune Response and Gut Systems. | Xu Y, Wang N, Tan HY, Li S, Zhang C, Feng Y. | Front Microbiol | 10.3389/fmicb.2020.00219 | 2020 | ||
| Maternal Intake of Probiotics to Program Offspring Health. | Cuinat C, Stinson SE, Ward WE, Comelli EM. | Curr Nutr Rep | 10.1007/s13668-022-00429-w | 2022 | ||
| Akkermansia muciniphila Enhances the Antitumor Effect of Cisplatin in Lewis Lung Cancer Mice. | Chen Z, Qian X, Chen S, Fu X, Ma G, Zhang A. | J Immunol Res | 10.1155/2020/2969287 | 2020 | ||
| Pathogenicity | Intestinal Epithelial Axin1 Deficiency Protects Against Colitis via Altered Gut Microbiota. | Garrett S, Zhang Y, Xia Y, Sun J. | Engineering (Beijing) | 10.1016/j.eng.2023.06.007 | 2024 | |
| Nanopore Sequencing of Amoebophrya Species Reveals Novel Collection of Bacteria Putatively Associated With Karlodinium veneficum. | Tizabi D, Hill RT, Bachvaroff T. | Genome Biol Evol | 10.1093/gbe/evaf022 | 2025 | ||
| Metabolism | Akkermansia muciniphila uses human milk oligosaccharides to thrive in the early life conditions in vitro. | Kostopoulos I, Elzinga J, Ottman N, Klievink JT, Blijenberg B, Aalvink S, Boeren S, Mank M, Knol J, de Vos WM, Belzer C. | Sci Rep | 10.1038/s41598-020-71113-8 | 2020 | |
| The anti-inflammatory effects of Akkermansia muciniphila and its derivates in HFD/CCL4-induced murine model of liver injury. | Raftar SKA, Ashrafian F, Abdollahiyan S, Yadegar A, Moradi HR, Masoumi M, Vaziri F, Moshiri A, Siadat SD, Zali MR. | Sci Rep | 10.1038/s41598-022-06414-1 | 2022 | ||
| Molecular Insights Into O-Linked Glycan Utilization by Gut Microbes. | Gonzalez-Morelo KJ, Vega-Sagardia M, Garrido D. | Front Microbiol | 10.3389/fmicb.2020.591568 | 2020 | ||
| MUP1 mediates urolithin A alleviation of chronic alcohol-related liver disease via gut-microbiota-liver axis. | Zhang H, Li C, Han L, Xiao Y, Bian J, Liu C, Gong L, Liu Z, Wang M. | Gut Microbes | 10.1080/19490976.2024.2367342 | 2024 | ||
| Stable colonization of Akkermansia muciniphila educates host intestinal microecology and immunity to battle against inflammatory intestinal diseases. | Wang B, Chen X, Chen Z, Xiao H, Dong J, Li Y, Zeng X, Liu J, Wan G, Fan S, Cui M. | Exp Mol Med | 10.1038/s12276-022-00911-z | 2023 | ||
| Genetics | Comparative Genomics Guides Elucidation of Vitamin B12 Biosynthesis in Novel Human-Associated Akkermansia Strains. | Kirmiz N, Galindo K, Cross KL, Luna E, Rhoades N, Podar M, Flores GE. | Appl Environ Microbiol | 10.1128/aem.02117-19 | 2020 | |
| Increased circulating butyrate and ursodeoxycholate during probiotic intervention in humans with type 2 diabetes. | McMurdie PJ, Stoeva MK, Justice N, Nemchek M, Sieber CMK, Tyagi S, Gines J, Skennerton CT, Souza M, Kolterman O, Eid J. | BMC Microbiol | 10.1186/s12866-021-02415-8 | 2022 | ||
| Lactobacillus acidophilus potentiates oncolytic virotherapy through modulating gut microbiota homeostasis in hepatocellular carcinoma. | Zhang J, Yang J, Luo J, Wu W, Luo H, Wei W, Lyu H, Wang Y, Yi H, Zhang Y, Fan Z, Lyu H, Kanakaveti VP, Qin B, Yuan P, Yang R, Zhang H, Zuo T, Felsher DW, Lee MH, Li K. | Nat Commun | 10.1038/s41467-025-58407-z | 2025 | ||
| Metabolism | Mucin degrader Akkermansia muciniphila accelerates intestinal stem cell-mediated epithelial development. | Kim S, Shin YC, Kim TY, Kim Y, Lee YS, Lee SH, Kim MN, O E, Kim KS, Kweon MN. | Gut Microbes | 10.1080/19490976.2021.1892441 | 2021 | |
| Genetics | Whole-genome assembly of Akkermansia muciniphila sequenced directly from human stool. | Caputo A, Dubourg G, Croce O, Gupta S, Robert C, Papazian L, Rolain JM, Raoult D. | Biol Direct | 10.1186/s13062-015-0041-1 | 2015 | |
| Tauroursodeoxycholic acid functions as a critical effector mediating insulin sensitization of metformin in obese mice. | Zhang Y, Cheng Y, Liu J, Zuo J, Yan L, Thring RW, Ba X, Qi D, Wu M, Gao Y, Tong H. | Redox Biol | 10.1016/j.redox.2022.102481 | 2022 | ||
| Pathogenicity | The Microbiota-Dependent Worsening Effects of Melatonin on Gut Inflammation. | da Silva JL, Barbosa LV, Pinzan CF, Nardini V, Brigo IS, Sebastiao CA, Elias-Oliveira J, Brazao V, Junior JCDP, Carlos D, Cardoso CRB. | Microorganisms | 10.3390/microorganisms11020460 | 2023 | |
| Metabolism | Modulation of serotonin signaling/metabolism by Akkermansia muciniphila and its extracellular vesicles through the gut-brain axis in mice. | Yaghoubfar R, Behrouzi A, Ashrafian F, Shahryari A, Moradi HR, Choopani S, Hadifar S, Vaziri F, Nojoumi SA, Fateh A, Khatami S, Siadat SD. | Sci Rep | 10.1038/s41598-020-79171-8 | 2020 | |
| Interaction of mouse splenocytes and macrophages with bacterial strains in vitro: the effect of age in the immune response. | Van Beek AA, Hoogerland JA, Belzer C, De Vos P, De Vos WM, Savelkoul HF, Leenen PJ. | Benef Microbes | 10.3920/bm2015.0094 | 2016 | ||
| The Regulation of Nucleic Acid Vaccine Responses by the Microbiome. | Johnson AMF, Hager K, Alameh MG, Van P, Potchen N, Mayer-Blackwell K, Fiore-Gartland A, Minot S, Lin PJC, Tam YK, Weissman D, Kublin JG. | J Immunol | 10.4049/jimmunol.2300196 | 2023 | ||
| Metabolism | Model-driven design of a minimal medium for Akkermansia muciniphila confirms mucus adaptation. | van der Ark KCH, Aalvink S, Suarez-Diez M, Schaap PJ, de Vos WM, Belzer C. | Microb Biotechnol | 10.1111/1751-7915.13033 | 2018 | |
| A novel monoclonal IgG1 antibody specific for Galactose-alpha-1,3-galactose questions alpha-Gal epitope expression by bacteria. | Kreft L, Schepers A, Hils M, Swiontek K, Flatley A, Janowski R, Mirzaei MK, Dittmar M, Chakrapani N, Desai MS, Eyerich S, Deng L, Niessing D, Fischer K, Feederle R, Blank S, Schmidt-Weber CB, Hilger C, Biedermann T, Ohnmacht C. | Front Immunol | 10.3389/fimmu.2022.958952 | 2022 | ||
| A genetic system for Akkermansia muciniphila reveals a role for mucin foraging in gut colonization and host sterol biosynthesis gene expression. | Davey LE, Malkus PN, Villa M, Dolat L, Holmes ZC, Letourneau J, Ansaldo E, David LA, Barton GM, Valdivia RH. | Nat Microbiol | 10.1038/s41564-023-01407-w | 2023 | ||
| HLA-II immunopeptidome profiling and deep learning reveal features of antigenicity to inform antigen discovery. | Strazar M, Park J, Abelin JG, Taylor HB, Pedersen TK, Plichta DR, Brown EM, Eraslan B, Hung YM, Ortiz K, Clauser KR, Carr SA, Xavier RJ, Graham DB. | Immunity | 10.1016/j.immuni.2023.05.009 | 2023 | ||
| Pathogenicity | Akkermansia muciniphila-Derived Extracellular Vesicles as a Mucosal Delivery Vector for Amelioration of Obesity in Mice. | Ashrafian F, Shahriary A, Behrouzi A, Moradi HR, Keshavarz Azizi Raftar S, Lari A, Hadifar S, Yaghoubfar R, Ahmadi Badi S, Khatami S, Vaziri F, Siadat SD. | Front Microbiol | 10.3389/fmicb.2019.02155 | 2019 | |
| GlcNac produced by the gut microbiome enhances host influenza resistance by modulating NK cells. | Hu X, Sun X, Zhao Y, Iv C, Sun X, Jin M, Zhang Q. | Gut Microbes | 10.1080/19490976.2023.2271620 | 2023 | ||
| Polyphenols as Drivers of a Homeostatic Gut Microecology and Immuno-Metabolic Traits of Akkermansia muciniphila: From Mouse to Man. | Rodriguez-Daza MC, de Vos WM. | Int J Mol Sci | 10.3390/ijms24010045 | 2022 | ||
| Dynamic metabolic interactions and trophic roles of human gut microbes identified using a minimal microbiome exhibiting ecological properties. | Shetty SA, Kostopoulos I, Geerlings SY, Smidt H, de Vos WM, Belzer C. | ISME J | 10.1038/s41396-022-01255-2 | 2022 | ||
| Pathogenicity | A mucin-regulated adhesin determines the spatial organization and inflammatory character of a bacterial symbiont in the vertebrate gut. | Smith TJ, Sundarraman D, Melancon E, Desban L, Parthasarathy R, Guillemin K. | Cell Host Microbe | 10.1016/j.chom.2023.07.003 | 2023 | |
| The effects of sodium butyrate and inulin supplementation on angiotensin signaling pathway via promotion of Akkermansia muciniphila abundance in type 2 diabetes; A randomized, double-blind, placebo-controlled trial. | Roshanravan N, Mahdavi R, Alizadeh E, Ghavami A, Rahbar Saadat Y, Mesri Alamdari N, Alipour S, Dastouri MR, Ostadrahimi A. | J Cardiovasc Thorac Res | 10.15171/jcvtr.2017.32 | 2017 | ||
| Metabolism | Modulation of the gut microbiota by metformin improves metabolic profiles in aged obese mice. | Lee H, Lee Y, Kim J, An J, Lee S, Kong H, Song Y, Lee CK, Kim K. | Gut Microbes | 10.1080/19490976.2017.1405209 | 2018 | |
| Functional environmental screening of a metagenomic library identifies stlA; a unique salt tolerance locus from the human gut microbiome. | Culligan EP, Sleator RD, Marchesi JR, Hill C. | PLoS One | 10.1371/journal.pone.0082985 | 2013 | ||
| Metabolism | Maternal Exposure to Non-nutritive Sweeteners Impacts Progeny's Metabolism and Microbiome. | Olivier-Van Stichelen S, Rother KI, Hanover JA. | Front Microbiol | 10.3389/fmicb.2019.01360 | 2019 | |
| Diet-derived metabolites and mucus link the gut microbiome to fever after cytotoxic cancer treatment. | Schwabkey ZI, Wiesnoski DH, Chang CC, Tsai WB, Pham D, Ahmed SS, Hayase T, Ortega Turrubiates MR, El-Himri RK, Sanchez CA, Hayase E, Frenk Oquendo AC, Miyama T, Halsey TM, Heckel BE, Brown AN, Jin Y, Raybaud M, Prasad R, Flores I, McDaniel L, Chapa V, Lorenzi PL, Warmoes MO, Tan L, Swennes AG, Fowler S, Conner M, McHugh K, Graf T, Jensen VB, Peterson CB, Do KA, Zhang L, Shi Y, Wang Y, Galloway-Pena JR, Okhuysen PC, Daniel-MacDougall CR, Shono Y, Burgos da Silva M, Peled JU, van den Brink MRM, Ajami N, Wargo JA, Reddy P, Valdivia RH, Davey L, Rondon G, Srour SA, Mehta RS, Alousi AM, Shpall EJ, Champlin RE, Shelburne SA, Molldrem JJ, Jamal MA, Karmouch JL, Jenq RR. | Sci Transl Med | 10.1126/scitranslmed.abo3445 | 2022 | ||
| Gut microbiota in regulatory T cell generation and function: mechanisms and health implications. | Sharma A, Sharma G, Im SH. | Gut Microbes | 10.1080/19490976.2025.2516702 | 2025 | ||
| Toxicological safety evaluation of pasteurized Akkermansia muciniphila. | Druart C, Plovier H, Van Hul M, Brient A, Phipps KR, de Vos WM, Cani PD. | J Appl Toxicol | 10.1002/jat.4044 | 2021 | ||
| Research advances in the therapy of metabolic syndrome. | Lin Z, Sun L. | Front Pharmacol | 10.3389/fphar.2024.1364881 | 2024 | ||
| Actively replicating gut bacteria identified by 5-ethynyl-2'-deoxyuridine (EdU) click chemistry and cell sorting. | Beauchemin ET, Hunter C, Maurice CF. | Gut Microbes | 10.1080/19490976.2023.2180317 | 2023 | ||
| Pathogenicity | Akkermansia muciniphila promotes type H vessel formation and bone fracture healing by reducing gut permeability and inflammation. | Liu JH, Yue T, Luo ZW, Cao J, Yan ZQ, Jin L, Wan TF, Shuai CJ, Wang ZG, Zhou Y, Xu R, Xie H. | Dis Model Mech | 10.1242/dmm.043620 | 2020 | |
| Pathogenicity | Wild blueberry proanthocyanidins shape distinct gut microbiota profile and influence glucose homeostasis and intestinal phenotypes in high-fat high-sucrose fed mice. | Rodriguez-Daza MC, Daoust L, Boutkrabt L, Pilon G, Varin T, Dudonne S, Levy E, Marette A, Roy D, Desjardins Y. | Sci Rep | 10.1038/s41598-020-58863-1 | 2020 | |
| The microbiome in inflammatory bowel diseases: from pathogenesis to therapy. | Liu S, Zhao W, Lan P, Mou X. | Protein Cell | 10.1007/s13238-020-00745-3 | 2021 | ||
| Recognizing the Benefits of Pre-/Probiotics in Metabolic Syndrome and Type 2 Diabetes Mellitus Considering the Influence of Akkermansia muciniphila as a Key Gut Bacterium. | Corb Aron RA, Abid A, Vesa CM, Nechifor AC, Behl T, Ghitea TC, Munteanu MA, Fratila O, Andronie-Cioara FL, Toma MM, Bungau S. | Microorganisms | 10.3390/microorganisms9030618 | 2021 | ||
| Update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA 12: suitability of taxonomic units notified to EFSA until March 2020. | EFSA Panel on Biological Hazards (BIOHAZ), Koutsoumanis K, Allende A, Alvarez-Ordonez A, Bolton D, Bover-Cid S, Chemaly M, Davies R, De Cesare A, Hilbert F, Lindqvist R, Nauta M, Peixe L, Ru G, Simmons M, Skandamis P, Suffredini E, Cocconcelli PS, Fernandez Escamez PS, Maradona MP, Querol A, Suarez JE, Sundh I, Vlak J, Barizzone F, Hempen M, Herman L. | EFSA J | 10.2903/j.efsa.2020.6174 | 2020 | ||
| Enzymology | 2-oxoglutarate:acceptor oxidoreductase-catalyzed redox cycling effectively targets coccoid forms of Helicobacter pylori. | Hang X, Lan W, Yanqiang H, Huang H, Zhang M, Zeng L, Shi T, Bai Y, Yang Z, Hu S, Wang J, Dong L, Tong Q, Jia J, Bi S, Xia Q, Gao Y, Bi H. | Nat Commun | 10.1038/s41467-025-62477-4 | 2025 | |
| A Computational Framework for Studying Gut-Brain Axis in Autism Spectrum Disorder. | Mohammad FK, Palukuri MV, Shivakumar S, Rengaswamy R, Sahoo S. | Front Physiol | 10.3389/fphys.2022.760753 | 2022 | ||
| Beneficial effect of the short-chain fatty acid propionate on vascular calcification through intestinal microbiota remodelling. | Yan J, Pan Y, Shao W, Wang C, Wang R, He Y, Zhang M, Wang Y, Li T, Wang Z, Liu W, Wang Z, Sun X, Dong S. | Microbiome | 10.1186/s40168-022-01390-0 | 2022 | ||
| Role of Postbiotics in Diabetes Mellitus: Current Knowledge and Future Perspectives. | Cabello-Olmo M, Arana M, Urtasun R, Encio IJ, Barajas M. | Foods | 10.3390/foods10071590 | 2021 | ||
| A new Illumina MiSeq high-throughput sequencing-based method for evaluating the composition of the Bacteroides community in the intestine using the rpsD gene sequence. | Wang C, Feng S, Xiao Y, Pan M, Zhao J, Zhang H, Zhai Q, Chen W. | Microb Biotechnol | 10.1111/1751-7915.13651 | 2021 | ||
| Enzymology | Precision modification of the human gut microbiota targeting surface-associated proteins. | Marcos-Fernandez R, Ruiz L, Blanco-Miguez A, Margolles A, Sanchez B. | Sci Rep | 10.1038/s41598-020-80187-3 | 2021 | |
| alpha-L-Fucosidases from an Alpaca Faeces Metagenome: Characterisation of Hydrolytic and Transfucosylation Potential. | Krupinskaite A, Stanislauskiene R, Serapinas P, Rutkiene R, Gasparaviciute R, Meskys R, Stankeviciute J. | Int J Mol Sci | 10.3390/ijms25020809 | 2024 | ||
| Gut microbiota suppress feeding induced by palatable foods. | Ousey J, Boktor JC, Mazmanian SK. | Curr Biol | 10.1016/j.cub.2022.10.066 | 2023 | ||
| A. muciniphila Supplementation in Mice during Pregnancy and Lactation Affects the Maternal Intestinal Microenvironment. | Qi Y, Yu L, Tian F, Zhao J, Zhang H, Chen W, Zhai Q. | Nutrients | 10.3390/nu14020390 | 2022 | ||
| Mucin-Degrading Microbes Release Monosaccharides That Chemoattract Clostridioides difficile and Facilitate Colonization of the Human Intestinal Mucus Layer. | Engevik MA, Engevik AC, Engevik KA, Auchtung JM, Chang-Graham AL, Ruan W, Luna RA, Hyser JM, Spinler JK, Versalovic J. | ACS Infect Dis | 10.1021/acsinfecdis.0c00634 | 2021 | ||
| Metabolism | Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions. | Chelakkot C, Choi Y, Kim DK, Park HT, Ghim J, Kwon Y, Jeon J, Kim MS, Jee YK, Gho YS, Park HS, Kim YK, Ryu SH. | Exp Mol Med | 10.1038/emm.2017.282 | 2018 | |
| Metabolism | Slimy partners: the mucus barrier and gut microbiome in ulcerative colitis. | Fang J, Wang H, Zhou Y, Zhang H, Zhou H, Zhang X. | Exp Mol Med | 10.1038/s12276-021-00617-8 | 2021 | |
| Genetics | Genotypic and Phenotypic Diversity among Human Isolates of Akkermansia muciniphila. | Becken B, Davey L, Middleton DR, Mueller KD, Sharma A, Holmes ZC, Dallow E, Remick B, Barton GM, David LA, McCann JR, Armstrong SC, Malkus P, Valdivia RH. | mBio | 10.1128/mbio.00478-21 | 2021 | |
| Metabolism | Interleukin-36 cytokines alter the intestinal microbiome and can protect against obesity and metabolic dysfunction. | Giannoudaki E, Hernandez-Santana YE, Mulfaul K, Doyle SL, Hams E, Fallon PG, Mat A, O'Shea D, Kopf M, Hogan AE, Walsh PT. | Nat Commun | 10.1038/s41467-019-11944-w | 2019 | |
| A Gram-negative-selective antibiotic that spares the gut microbiome. | Munoz KA, Ulrich RJ, Vasan AK, Sinclair M, Wen PC, Holmes JR, Lee HY, Hung CC, Fields CJ, Tajkhorshid E, Lau GW, Hergenrother PJ. | Nature | 10.1038/s41586-024-07502-0 | 2024 | ||
| Evolutionary Insights Into Microbiota Transplantation in Inflammatory Bowel Disease. | Wang X, Zhao J, Feng Y, Feng Z, Ye Y, Liu L, Kang G, Cao X. | Front Cell Infect Microbiol | 10.3389/fcimb.2022.916543 | 2022 | ||
| Untargeted Metabolomics Sensitively Differentiates Gut Bacterial Species in Single Culture and Co-Culture Systems. | Zhang S, Zhu J. | ACS Omega | 10.1021/acsomega.1c07114 | 2022 | ||
| 13C-Stable isotope resolved metabolomics uncovers dynamic biochemical landscape of gut microbiome-host organ communications in mice. | Xiao X, Zhou Y, Li X, Jin J, Durham J, Ye Z, Wang Y, Hennig B, Deng P. | Microbiome | 10.1186/s40168-024-01808-x | 2024 | ||
| Enzymology | Two distinct gut microbial pathways contribute to meta-organismal production of phenylacetylglutamine with links to cardiovascular disease. | Zhu Y, Dwidar M, Nemet I, Buffa JA, Sangwan N, Li XS, Anderson JT, Romano KA, Fu X, Funabashi M, Wang Z, Keranahalli P, Battle S, Tittle AN, Hajjar AM, Gogonea V, Fischbach MA, DiDonato JA, Hazen SL. | Cell Host Microbe | 10.1016/j.chom.2022.11.015 | 2023 | |
| Akkermansia muciniphila in the Human Gastrointestinal Tract: When, Where, and How? | Geerlings SY, Kostopoulos I, de Vos WM, Belzer C. | Microorganisms | 10.3390/microorganisms6030075 | 2018 | ||
| Metabolism | Genome-Scale Model and Omics Analysis of Metabolic Capacities of Akkermansia muciniphila Reveal a Preferential Mucin-Degrading Lifestyle. | Ottman N, Davids M, Suarez-Diez M, Boeren S, Schaap PJ, Martins Dos Santos VAP, Smidt H, Belzer C, de Vos WM. | Appl Environ Microbiol | 10.1128/aem.01014-17 | 2017 | |
| Metabolism | Deciphering the trophic interaction between Akkermansia muciniphila and the butyrogenic gut commensal Anaerostipes caccae using a metatranscriptomic approach. | Chia LW, Hornung BVH, Aalvink S, Schaap PJ, de Vos WM, Knol J, Belzer C. | Antonie Van Leeuwenhoek | 10.1007/s10482-018-1040-x | 2018 | |
| Enzymology | Polyphenol-Mediated Gut Microbiota Modulation: Toward Prebiotics and Further. | Rodriguez-Daza MC, Pulido-Mateos EC, Lupien-Meilleur J, Guyonnet D, Desjardins Y, Roy D. | Front Nutr | 10.3389/fnut.2021.689456 | 2021 | |
| Gut microbiota as an antioxidant system in centenarians associated with high antioxidant activities of gut-resident Lactobacillus. | Wu L, Xie X, Li Y, Liang T, Zhong H, Yang L, Xi Y, Zhang J, Ding Y, Wu Q. | NPJ Biofilms Microbiomes | 10.1038/s41522-022-00366-0 | 2022 | ||
| Bacterial PncA improves diet-induced NAFLD in mice by enabling the transition from nicotinamide to nicotinic acid. | Feng S, Guo L, Wang H, Yang S, Liu H. | Commun Biol | 10.1038/s42003-023-04613-8 | 2023 | ||
| Pathogenicity | Grape proanthocyanidin-induced intestinal bloom of Akkermansia muciniphila is dependent on its baseline abundance and precedes activation of host genes related to metabolic health. | Zhang L, Carmody RN, Kalariya HM, Duran RM, Moskal K, Poulev A, Kuhn P, Tveter KM, Turnbaugh PJ, Raskin I, Roopchand DE. | J Nutr Biochem | 10.1016/j.jnutbio.2018.02.009 | 2018 | |
| The microenvironment of injured murine gut elicits a local pro-restitutive microbiota. | Alam A, Leoni G, Quiros M, Wu H, Desai C, Nishio H, Jones RM, Nusrat A, Neish AS. | Nat Microbiol | 10.1038/nmicrobiol.2015.21 | 2016 | ||
| Genetics | Understanding the Representative Gut Microbiota Dysbiosis in Metformin-Treated Type 2 Diabetes Patients Using Genome-Scale Metabolic Modeling. | Rosario D, Benfeitas R, Bidkhori G, Zhang C, Uhlen M, Shoaie S, Mardinoglu A. | Front Physiol | 10.3389/fphys.2018.00775 | 2018 | |
| Safety of Novel Microbes for Human Consumption: Practical Examples of Assessment in the European Union. | Brodmann T, Endo A, Gueimonde M, Vinderola G, Kneifel W, de Vos WM, Salminen S, Gomez-Gallego C. | Front Microbiol | 10.3389/fmicb.2017.01725 | 2017 | ||
| THE SMALL INTESTINAL MICROBIOME: VIBING WITH INTESTINAL STEM CELLS. | Poplaski V, Sawyer F, Blutt SE. | Microbiota Host | 10.1530/mah-23-0012 | 2023 | ||
| Structure similarity and molecular networking analysis for the discovery of polyphenol biotransformation products of gut microbes. | Xu R, Lee J, Zhang S, Chen L, Zhu J. | Anal Chim Acta | 10.1016/j.aca.2022.340145 | 2022 | ||
| Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice. | Shono Y, Docampo MD, Peled JU, Perobelli SM, Velardi E, Tsai JJ, Slingerland AE, Smith OM, Young LF, Gupta J, Lieberman SR, Jay HV, Ahr KF, Porosnicu Rodriguez KA, Xu K, Calarfiore M, Poeck H, Caballero S, Devlin SM, Rapaport F, Dudakov JA, Hanash AM, Gyurkocza B, Murphy GF, Gomes C, Liu C, Moss EL, Falconer SB, Bhatt AS, Taur Y, Pamer EG, van den Brink MRM, Jenq RR. | Sci Transl Med | 10.1126/scitranslmed.aaf2311 | 2016 | ||
| Genetics | A Comparative Analysis of Biosynthetic Gene Clusters in Lean and Obese Humans. | Wang S, Li N, Li N, Zou H, Wu M. | Biomed Res Int | 10.1155/2019/6361320 | 2019 | |
| Pathogenicity | Triggering Akkermansia with dietary polyphenols: A new weapon to combat the metabolic syndrome? | Anhe FF, Pilon G, Roy D, Desjardins Y, Levy E, Marette A. | Gut Microbes | 10.1080/19490976.2016.1142036 | 2016 | |
| Increasing breast milk betaine modulates Akkermansia abundance in mammalian neonates and improves long-term metabolic health. | Ribo S, Sanchez-Infantes D, Martinez-Guino L, Garcia-Mantrana I, Ramon-Krauel M, Tondo M, Arning E, Nofrarias M, Osorio-Conles O, Fernandez-Perez A, Gonzalez-Torres P, Cebria J, Gavalda-Navarro A, Chenoll E, Isganaitis E, Villarroya F, Vallejo M, Segales J, Jimenez-Chillaron JC, Bottiglieri T, Demerath EW, Fields DA, Collado MC, Lerin C. | Sci Transl Med | 10.1126/scitranslmed.abb0322 | 2021 | ||
| Metabolism | The genome of Akkermansia muciniphila, a dedicated intestinal mucin degrader, and its use in exploring intestinal metagenomes. | van Passel MW, Kant R, Zoetendal EG, Plugge CM, Derrien M, Malfatti SA, Chain PS, Woyke T, Palva A, de Vos WM, Smidt H. | PLoS One | 10.1371/journal.pone.0016876 | 2011 | |
| Intelectin-1 binds and alters the localization of the mucus barrier-modifying bacterium Akkermansia muciniphila. | Matute JD, Duan J, Flak MB, Griebel P, Tascon-Arcila JA, Doms S, Hanley T, Antanaviciute A, Gundrum J, Mark Welch JL, Sit B, Abtahi S, Fuhler GM, Grootjans J, Tran F, Stengel ST, White JR, Krupka N, Haller D, Clare S, Lawley TD, Kaser A, Simmons A, Glickman JN, Bry L, Rosenstiel P, Borisy G, Waldor MK, Baines JF, Turner JR, Blumberg RS. | J Exp Med | 10.1084/jem.20211938 | 2023 | ||
| Host Age Prediction from Fecal Microbiota Composition in Male C57BL/6J Mice. | Low A, Soh M, Miyake S, Seedorf H. | Microbiol Spectr | 10.1128/spectrum.00735-22 | 2022 | ||
| The gut microbiome of laboratory mice: considerations and best practices for translational research. | Ericsson AC, Franklin CL. | Mamm Genome | 10.1007/s00335-021-09863-7 | 2021 | ||
| Retinoid acid induced 16 deficiency aggravates colitis and colitis-associated tumorigenesis in mice. | Xu YL, Ding CL, Qian CL, Qi ZT, Wang W. | Cell Death Dis | 10.1038/s41419-019-2186-9 | 2019 | ||
| Culturing of a complex gut microbial community in mucin-hydrogel carriers reveals strain- and gene-associated spatial organization. | Jin X, Yu FB, Yan J, Weakley AM, Dubinkina V, Meng X, Pollard KS. | Nat Commun | 10.1038/s41467-023-39121-0 | 2023 | ||
| A Soybean Resistant Protein-Containing Diet Increased the Production of Reg3gamma Through the Regulation of the Gut Microbiota and Enhanced the Intestinal Barrier Function in Mice. | Ogita T, Namai F, Mikami A, Ishiguro T, Umezawa K, Uyeno Y, Shimosato T. | Front Nutr | 10.3389/fnut.2021.701466 | 2021 | ||
| Exploring the sequence-function space of microbial fucosidases. | Martinez Gascuena A, Wu H, Wang R, Owen CD, Hernando PJ, Monaco S, Penner M, Xing K, Le Gall G, Gardner R, Ndeh D, Urbanowicz PA, Spencer DIR, Walsh M, Angulo J, Juge N. | Commun Chem | 10.1038/s42004-024-01212-4 | 2024 | ||
| Evolution of endonuclease IV protein family: an in silico analysis. | Kanchan S, Sharma P, Chowdhury S. | 3 Biotech | 10.1007/s13205-019-1696-6 | 2019 | ||
| Genetics | Reconstruction of Bacterial and Viral Genomes from Multiple Metagenomes. | Gupta A, Kumar S, Prasoodanan VP, Harish K, Sharma AK, Sharma VK. | Front Microbiol | 10.3389/fmicb.2016.00469 | 2016 | |
| Metabolism | Extracellular Vesicles from Child Gut Microbiota Enter into Bone to Preserve Bone Mass and Strength. | Liu JH, Chen CY, Liu ZZ, Luo ZW, Rao SS, Jin L, Wan TF, Yue T, Tan YJ, Yin H, Yang F, Huang FY, Guo J, Wang YY, Xia K, Cao J, Wang ZX, Hong CG, Luo MJ, Hu XK, Liu YW, Du W, Luo J, Hu Y, Zhang Y, Huang J, Li HM, Wu B, Liu HM, Chen TH, Qian YX, Li YY, Feng SK, Chen Y, Qi LY, Xu R, Tang SY, Xie H. | Adv Sci (Weinh) | 10.1002/advs.202004831 | 2021 | |
| Metabolism | Lactobacillus rhamnosus GG Derived Extracellular Vesicles Modulate Gut Microbiota and Attenuate Inflammatory in DSS-Induced Colitis Mice. | Tong L, Zhang X, Hao H, Liu Q, Zhou Z, Liang X, Liu T, Gong P, Zhang L, Zhai Z, Hao Y, Yi H. | Nutrients | 10.3390/nu13103319 | 2021 | |
| Pathogenicity | Polyphenol- and Caffeine-Rich Postfermented Pu-erh Tea Improves Diet-Induced Metabolic Syndrome by Remodeling Intestinal Homeostasis in Mice. | Gao X, Xie Q, Kong P, Liu L, Sun S, Xiong B, Huang B, Yan L, Sheng J, Xiang H. | Infect Immun | 10.1128/iai.00601-17 | 2018 | |
| Metabolism | Akkermansia muciniphila mediates negative effects of IFNgamma on glucose metabolism. | Greer RL, Dong X, Moraes AC, Zielke RA, Fernandes GR, Peremyslova E, Vasquez-Perez S, Schoenborn AA, Gomes EP, Pereira AC, Ferreira SR, Yao M, Fuss IJ, Strober W, Sikora AE, Taylor GA, Gulati AS, Morgun A, Shulzhenko N. | Nat Commun | 10.1038/ncomms13329 | 2016 | |
| Metabolism | Identification of Allobaculum mucolyticum as a novel human intestinal mucin degrader. | van Muijlwijk GH, van Mierlo G, Jansen PWTC, Vermeulen M, Bleumink-Pluym NMC, Palm NW, van Putten JPM, de Zoete MR. | Gut Microbes | 10.1080/19490976.2021.1966278 | 2021 | |
| Berry Polyphenols and Fibers Modulate Distinct Microbial Metabolic Functions and Gut Microbiota Enterotype-Like Clustering in Obese Mice. | Rodriguez-Daza MC, Roquim M, Dudonne S, Pilon G, Levy E, Marette A, Roy D, Desjardins Y. | Front Microbiol | 10.3389/fmicb.2020.02032 | 2020 | ||
| A decrease in functional microbiomes represented as Faecalibacterium affects immune homeostasis in long-term stable liver transplant patients. | Lee SK, Jhun J, Lee SY, Choi S, Choi SS, Park MS, Lee SY, Cho KH, Lee AR, Ahn J, Choi HJ, You YK, Sung PS, Jang JW, Bae SH, Yoon SK, Cho ML, Choi JY. | Gut Microbes | 10.1080/19490976.2022.2102885 | 2022 | ||
| Altered microbiota associated with abnormal humoral immune responses to commensal organisms in enthesitis-related arthritis. | Stoll ML, Kumar R, Morrow CD, Lefkowitz EJ, Cui X, Genin A, Cron RQ, Elson CO. | Arthritis Res Ther | 10.1186/s13075-014-0486-0 | 2014 | ||
| Commensal epitopes drive differentiation of colonic Tregs. | Kuczma MP, Szurek EA, Cebula A, Chassaing B, Jung YJ, Kang SM, Fox JG, Stecher B, Ignatowicz L. | Sci Adv | 10.1126/sciadv.aaz3186 | 2020 | ||
| Deep-learning-enabled antibiotic discovery through molecular de-extinction. | Wan F, Torres MDT, Peng J, de la Fuente-Nunez C. | Nat Biomed Eng | 10.1038/s41551-024-01201-x | 2024 | ||
| Enzymology | Kinetics and structural features of dimeric glutamine-dependent bacterial NAD+ synthetases suggest evolutionary adaptation to available metabolites. | Santos ARS, Gerhardt ECM, Moure VR, Pedrosa FO, Souza EM, Diamanti R, Hogbom M, Huergo LF. | J Biol Chem | 10.1074/jbc.ra118.002241 | 2018 | |
| Metabolism | Extracellular vesicles derived from gut microbiota, especially Akkermansia muciniphila, protect the progression of dextran sulfate sodium-induced colitis. | Kang CS, Ban M, Choi EJ, Moon HG, Jeon JS, Kim DK, Park SK, Jeon SG, Roh TY, Myung SJ, Gho YS, Kim JG, Kim YK. | PLoS One | 10.1371/journal.pone.0076520 | 2013 | |
| Genetic and environmental control of host-gut microbiota interactions. | Org E, Org E, Parks BW, Joo JW, Emert B, Schwartzman W, Kang EY, Mehrabian M, Pan C, Knight R, Gunsalus R, Drake TA, Eskin E, Lusis AJ. | Genome Res | 10.1101/gr.194118.115 | 2015 | ||
| Metabolism | Distribution of glucan-branching enzymes among prokaryotes. | Suzuki E, Suzuki R. | Cell Mol Life Sci | 10.1007/s00018-016-2243-9 | 2016 | |
| Single-strain behavior predicts responses to environmental pH and osmolality in the gut microbiota. | Ng KM, Pannu S, Liu S, Burckhardt JC, Hughes T, Van Treuren W, Nguyen J, Naqvi K, Nguyen B, Clayton CA, Pepin DM, Collins SR, Tropini C. | mBio | 10.1128/mbio.00753-23 | 2023 | ||
| Prospects of Probiotic Adjuvant Drugs in Clinical Treatment. | Ren Z, Hong Y, Huo Y, Peng L, Lv H, Chen J, Wu Z, Wan C. | Nutrients | 10.3390/nu14224723 | 2022 | ||
| SARS-CoV-2-specific T cells in unexposed adults display broad trafficking potential and cross-react with commensal antigens. | Bartolo L, Afroz S, Pan YG, Xu R, Williams L, Lin CF, Tanes C, Bittinger K, Friedman ES, Gimotty PA, Wu GD, Su LF. | Sci Immunol | 10.1126/sciimmunol.abn3127 | 2022 | ||
| Intracellular Fusobacterium nucleatum infection attenuates antitumor immunity in esophageal squamous cell carcinoma. | Li Y, Xing S, Chen F, Li Q, Dou S, Huang Y, An J, Liu W, Zhang G. | Nat Commun | 10.1038/s41467-023-40987-3 | 2023 | ||
| Enzymology | A reverse metabolic approach to weaning: in silico identification of immune-beneficial infant gut bacteria, mining their metabolism for prebiotic feeds and sourcing these feeds in the natural product space. | Michelini S, Balakrishnan B, Parolo S, Matone A, Mullaney JA, Young W, Gasser O, Wall C, Priami C, Lombardo R, Kussmann M. | Microbiome | 10.1186/s40168-018-0545-x | 2018 | |
| Enzymology | Comparison of bacterial quantities in left and right colon biopsies and faeces. | Lyra A, Forssten S, Rolny P, Wettergren Y, Lahtinen SJ, Salli K, Cedgard L, Odin E, Gustavsson B, Ouwehand AC. | World J Gastroenterol | 10.3748/wjg.v18.i32.4404 | 2012 | |
| Dietary Polyphenols Promote Growth of the Gut Bacterium Akkermansia muciniphila and Attenuate High-Fat Diet-Induced Metabolic Syndrome. | Roopchand DE, Carmody RN, Kuhn P, Moskal K, Rojas-Silva P, Turnbaugh PJ, Raskin I. | Diabetes | 10.2337/db14-1916 | 2015 | ||
| Metabolism | Strain dropouts reveal interactions that govern the metabolic output of the gut microbiome. | Wang M, Osborn LJ, Jain S, Meng X, Weakley A, Yan J, Massey WJ, Varadharajan V, Horak A, Banerjee R, Allende DS, Chan ER, Hajjar AM, Wang Z, Dimas A, Zhao A, Nagashima K, Cheng AG, Higginbottom S, Hazen SL, Brown JM, Fischbach MA. | Cell | 10.1016/j.cell.2023.05.037 | 2023 | |
| Genetics | Strain/species identification in metagenomes using genome-specific markers. | Tu Q, He Z, Zhou J. | Nucleic Acids Res | 10.1093/nar/gku138 | 2014 | |
| Microbial Metabolic Capacity for Intestinal Folate Production and Modulation of Host Folate Receptors. | Engevik MA, Morra CN, Roth D, Engevik K, Spinler JK, Devaraj S, Crawford SE, Estes MK, Kalkum M, Versalovic J. | Front Microbiol | 10.3389/fmicb.2019.02305 | 2019 | ||
| Mechanistic Insights Into the Cross-Feeding of Ruminococcus gnavus and Ruminococcus bromii on Host and Dietary Carbohydrates. | Crost EH, Le Gall G, Laverde-Gomez JA, Mukhopadhya I, Flint HJ, Juge N. | Front Microbiol | 10.3389/fmicb.2018.02558 | 2018 | ||
| Metabolism | Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly. | Collado MC, Derrien M, Isolauri E, de Vos WM, Salminen S. | Appl Environ Microbiol | 10.1128/aem.01477-07 | 2007 | |
| Commensal Akkermansia muciniphila exacerbates gut inflammation in Salmonella Typhimurium-infected gnotobiotic mice. | Ganesh BP, Klopfleisch R, Loh G, Blaut M. | PLoS One | 10.1371/journal.pone.0074963 | 2013 | ||
| The prevalence of species and strains in the human microbiome: a resource for experimental efforts. | Kraal L, Abubucker S, Kota K, Fischbach MA, Mitreva M. | PLoS One | 10.1371/journal.pone.0097279 | 2014 | ||
| Mucin glycan foraging in the human gut microbiome. | Tailford LE, Crost EH, Kavanaugh D, Juge N. | Front Genet | 10.3389/fgene.2015.00081 | 2015 | ||
| Depletion of the diabetic gut microbiota resistance enhances stem cells therapy in type 1 diabetes mellitus. | Lv W, Graves DT, He L, Shi Y, Deng X, Zhao Y, Dong X, Ren Y, Liu X, Xiao E, Zhang Y. | Theranostics | 10.7150/thno.44113 | 2020 | ||
| Veillonella, Firmicutes: Microbes disguised as Gram negatives. | Vesth T, Ozen A, Andersen SC, Kaas RS, Lukjancenko O, Bohlin J, Nookaew I, Wassenaar TM, Ussery DW. | Stand Genomic Sci | 10.4056/sigs.2981345 | 2013 | ||
| Pathogenicity | Enterococcus faecalis Sex Pheromone cCF10 Enhances Conjugative Plasmid Transfer In Vivo. | Hirt H, Greenwood-Quaintance KE, Karau MJ, Till LM, Kashyap PC, Patel R, Dunny GM. | mBio | 10.1128/mbio.00037-18 | 2018 | |
| Methionine restriction-induced sulfur deficiency impairs antitumour immunity partially through gut microbiota. | Ji M, Xu X, Xu Q, Hsiao YC, Martin C, Ukraintseva S, Popov V, Arbeev KG, Randall TA, Wu X, Garcia-Peterson LM, Liu J, Xu X, Andrea Azcarate-Peril M, Wan Y, Yashin AI, Anantharaman K, Lu K, Li JL, Shats I, Li X. | Nat Metab | 10.1038/s42255-023-00854-3 | 2023 | ||
| Host-compound foraging by intestinal microbiota revealed by single-cell stable isotope probing. | Berry D, Stecher B, Schintlmeister A, Reichert J, Brugiroux S, Wild B, Wanek W, Richter A, Rauch I, Decker T, Loy A, Wagner M. | Proc Natl Acad Sci U S A | 10.1073/pnas.1219247110 | 2013 | ||
| Genetics | Functional metagenomics reveals novel salt tolerance loci from the human gut microbiome. | Culligan EP, Sleator RD, Marchesi JR, Hill C. | ISME J | 10.1038/ismej.2012.38 | 2012 | |
| Dynamic Modulation of the Gut Microbiota and Metabolome by Bacteriophages in a Mouse Model. | Hsu BB, Gibson TE, Yeliseyev V, Liu Q, Lyon L, Bry L, Silver PA, Gerber GK. | Cell Host Microbe | 10.1016/j.chom.2019.05.001 | 2019 | ||
| Design, construction, and in vivo augmentation of a complex gut microbiome. | Cheng AG, Ho PY, Aranda-Diaz A, Jain S, Yu FB, Meng X, Wang M, Iakiviak M, Nagashima K, Zhao A, Murugkar P, Patil A, Atabakhsh K, Weakley A, Yan J, Brumbaugh AR, Higginbottom S, Dimas A, Shiver AL, Deutschbauer A, Neff N, Sonnenburg JL, Huang KC, Fischbach MA. | Cell | 10.1016/j.cell.2022.08.003 | 2022 | ||
| Peptidoglycan: a post-genomic analysis. | Cayrou C, Henrissat B, Gouret P, Pontarotti P, Drancourt M. | BMC Microbiol | 10.1186/1471-2180-12-294 | 2012 | ||
| A dietary isothiocyanate-enriched moringa (Moringa oleifera) seed extract improves glucose tolerance in a high-fat-diet mouse model and modulates the gut microbiome. | Jaja-Chimedza A, Zhang L, Wolff K, Graf BL, Kuhn P, Moskal K, Carmouche R, Newman S, Salbaum JM, Raskin I. | J Funct Foods | 10.1016/j.jff.2018.05.056 | 2018 | ||
| Genetics | Analysis of genome content evolution in pvc bacterial super-phylum: assessment of candidate genes associated with cellular organization and lifestyle. | Kamneva OK, Knight SJ, Liberles DA, Ward NL. | Genome Biol Evol | 10.1093/gbe/evs113 | 2012 | |
| Metabolism | Comparative analysis of the extracellular proteomes of two Clostridium sordellii strains exhibiting contrasting virulence. | Kachman MT, Hurley MC, Thiele T, Srinivas G, Aronoff DM. | Anaerobe | 10.1016/j.anaerobe.2010.03.004 | 2010 | |
| Metagenomic profiling of known and unknown microbes with microbeGPS. | Lindner MS, Renard BY. | PLoS One | 10.1371/journal.pone.0117711 | 2015 | ||
| Genetics | Environmental Metagenomic Assemblies Reveal Seven New Highly Divergent Chlamydial Lineages and Hallmarks of a Conserved Intracellular Lifestyle. | Pillonel T, Bertelli C, Greub G. | Front Microbiol | 10.3389/fmicb.2018.00079 | 2018 | |
| Phylogeny | Combining 16S rRNA gene variable regions enables high-resolution microbial community profiling. | Fuks G, Elgart M, Amir A, Zeisel A, Turnbaugh PJ, Soen Y, Shental N. | Microbiome | 10.1186/s40168-017-0396-x | 2018 | |
| The Glutaminase-Dependent Acid Resistance System: Qualitative and Quantitative Assays and Analysis of Its Distribution in Enteric Bacteria. | Pennacchietti E, D'Alonzo C, Freddi L, Occhialini A, De Biase D. | Front Microbiol | 10.3389/fmicb.2018.02869 | 2018 | ||
| BacArena: Individual-based metabolic modeling of heterogeneous microbes in complex communities. | Bauer E, Zimmermann J, Baldini F, Thiele I, Kaleta C. | PLoS Comput Biol | 10.1371/journal.pcbi.1005544 | 2017 | ||
| Genetics | DciA is an ancestral replicative helicase operator essential for bacterial replication initiation. | Brezellec P, Vallet-Gely I, Possoz C, Quevillon-Cheruel S, Ferat JL. | Nat Commun | 10.1038/ncomms13271 | 2016 | |
| Pathogenicity | Probiotic and commensal gut microbial therapies in multiple sclerosis and its animal models: a comprehensive review. | Blais LL, Montgomery TL, Amiel E, Deming PB, Krementsov DN. | Gut Microbes | 10.1080/19490976.2021.1943289 | 2021 | |
| Metabolism | Modulation of Gut Microbiota Composition by Serotonin Signaling Influences Intestinal Immune Response and Susceptibility to Colitis. | Kwon YH, Wang H, Denou E, Ghia JE, Rossi L, Fontes ME, Bernier SP, Shajib MS, Banskota S, Collins SM, Surette MG, Khan WI. | Cell Mol Gastroenterol Hepatol | 10.1016/j.jcmgh.2019.01.004 | 2019 | |
| Assessing Bacterial Interactions Using Carbohydrate-Based Microarrays. | Flannery A, Gerlach JQ, Joshi L, Kilcoyne M. | Microarrays (Basel) | 10.3390/microarrays4040690 | 2015 | ||
| Genetics | Assessment of k-mer spectrum applicability for metagenomic dissimilarity analysis. | Dubinkina VB, Ischenko DS, Ulyantsev VI, Tyakht AV, Alexeev DG. | BMC Bioinformatics | 10.1186/s12859-015-0875-7 | 2016 | |
| A novel extracellular metallopeptidase domain shared by animal host-associated mutualistic and pathogenic microbes. | Nakjang S, Ndeh DA, Wipat A, Bolam DN, Hirt RP. | PLoS One | 10.1371/journal.pone.0030287 | 2012 | ||
| Pathogenicity | Dietary Fructose Alters the Composition, Localization, and Metabolism of Gut Microbiota in Association With Worsening Colitis. | Montrose DC, Nishiguchi R, Basu S, Staab HA, Zhou XK, Wang H, Meng L, Johncilla M, Cubillos-Ruiz JR, Morales DK, Wells MT, Simpson KW, Zhang S, Dogan B, Jiao C, Fei Z, Oka A, Herzog JW, Sartor RB, Dannenberg AJ. | Cell Mol Gastroenterol Hepatol | 10.1016/j.jcmgh.2020.09.008 | 2021 | |
| Metabolism | Reshaping of bacterial molecular hydrogen metabolism contributes to the outgrowth of commensal E. coli during gut inflammation. | Hughes ER, Winter MG, Alves da Silva L, Muramatsu MK, Jimenez AG, Gillis CC, Spiga L, Chanin RB, Santos RL, Zhu W, Winter SE. | Elife | 10.7554/elife.58609 | 2021 | |
| Dissemination of 6S RNA among bacteria. | Wehner S, Damm K, Hartmann RK, Marz M. | RNA Biol | 10.4161/rna.29894 | 2014 | ||
| Phylogeny | The human gut chip "HuGChip", an explorative phylogenetic microarray for determining gut microbiome diversity at family level. | Tottey W, Denonfoux J, Jaziri F, Parisot N, Missaoui M, Hill D, Borrel G, Peyretaillade E, Alric M, Harris HM, Jeffery IB, Claesson MJ, O'Toole PW, Peyret P, Brugere JF. | PLoS One | 10.1371/journal.pone.0062544 | 2013 | |
| Intestinal microbiota as modulators of the immune system and neuroimmune system: impact on the host health and homeostasis. | Maranduba CM, De Castro SB, de Souza GT, Rossato C, da Guia FC, Valente MA, Rettore JV, Maranduba CP, de Souza CM, do Carmo AM, Macedo GC, Silva Fde S. | J Immunol Res | 10.1155/2015/931574 | 2015 | ||
| Metabolism | Capturing single cell genomes of active polysaccharide degraders: an unexpected contribution of Verrucomicrobia. | Martinez-Garcia M, Brazel DM, Swan BK, Arnosti C, Chain PS, Reitenga KG, Xie G, Poulton NJ, Lluesma Gomez M, Masland DE, Thompson B, Bellows WK, Ziervogel K, Lo CC, Ahmed S, Gleasner CD, Detter CJ, Stepanauskas R. | PLoS One | 10.1371/journal.pone.0035314 | 2012 | |
| Deciphering interactions between the gut microbiota and the immune system via microbial cultivation and minimal microbiomes. | Clavel T, Gomes-Neto JC, Lagkouvardos I, Ramer-Tait AE. | Immunol Rev | 10.1111/imr.12578 | 2017 | ||
| Genetics | A comprehensive benchmarking study of protocols and sequencing platforms for 16S rRNA community profiling. | D'Amore R, Ijaz UZ, Schirmer M, Kenny JG, Gregory R, Darby AC, Shakya M, Podar M, Quince C, Hall N. | BMC Genomics | 10.1186/s12864-015-2194-9 | 2016 | |
| Enzymology | Complete genome sequence of the extremely acidophilic methanotroph isolate V4, Methylacidiphilum infernorum, a representative of the bacterial phylum Verrucomicrobia. | Hou S, Makarova KS, Saw JH, Senin P, Ly BV, Zhou Z, Ren Y, Wang J, Galperin MY, Omelchenko MV, Wolf YI, Yutin N, Koonin EV, Stott MB, Mountain BW, Crowe MA, Smirnova AV, Dunfield PF, Feng L, Wang L, Alam M. | Biol Direct | 10.1186/1745-6150-3-26 | 2008 | |
| Phylogeny | Genome-Resolved Metagenomics Extends the Environmental Distribution of the Verrucomicrobia Phylum to the Deep Terrestrial Subsurface. | Nixon SL, Daly RA, Borton MA, Solden LM, Welch SA, Cole DR, Mouser PJ, Wilkins MJ, Wrighton KC. | mSphere | 10.1128/msphere.00613-19 | 2019 | |
| Noncellulosomal cohesin- and dockerin-like modules in the three domains of life. | Peer A, Smith SP, Bayer EA, Lamed R, Borovok I. | FEMS Microbiol Lett | 10.1111/j.1574-6968.2008.01420.x | 2009 | ||
| Bambus 2: scaffolding metagenomes. | Koren S, Treangen TJ, Pop M. | Bioinformatics | 10.1093/bioinformatics/btr520 | 2011 | ||
| Comprehensive prediction of chromosome dimer resolution sites in bacterial genomes. | Kono N, Arakawa K, Tomita M. | BMC Genomics | 10.1186/1471-2164-12-19 | 2011 | ||
| Ecophysiology of Freshwater Verrucomicrobia Inferred from Metagenome-Assembled Genomes. | He S, Stevens SLR, Chan LK, Bertilsson S, Glavina Del Rio T, Tringe SG, Malmstrom RR, McMahon KD. | mSphere | 10.1128/msphere.00277-17 | 2017 | ||
| Genetics | Information theoretic perspective on genome clustering. | Veluchamy A, Mehta P, Srividhya KV, Vikram H, Govind MK, Gupta R, Aziz Bin Dukhyil A, Abdullah Alharbi R, Abdullah Aloyuni S, Hassan MM, Krishnaswamy S. | Saudi J Biol Sci | 10.1016/j.sjbs.2020.12.039 | 2021 | |
| Annotation of Protein Domains Reveals Remarkable Conservation in the Functional Make up of Proteomes Across Superkingdoms. | Nasir A, Naeem A, Khan MJ, Nicora HD, Caetano-Anolles G. | Genes (Basel) | 10.3390/genes2040869 | 2011 | ||
| Bioinformatic characterization of the trimeric intracellular cation-specific channel protein family. | Silverio AL, Saier MH. | J Membr Biol | 10.1007/s00232-011-9364-8 | 2011 | ||
| Next Generation Probiotics for Neutralizing Obesogenic Effects: Taxa Culturing Searching Strategies. | Lopez-Moreno A, Acuna I, Torres-Sanchez A, Ruiz-Moreno A, Cerk K, Rivas A, Suarez A, Monteoliva-Sanchez M, Aguilera M. | Nutrients | 10.3390/nu13051617 | 2021 | ||
| Different Intestinal Microbial Profile in Over-Weight and Obese Subjects Consuming a Diet with Low Content of Fiber and Antioxidants. | Fernandez-Navarro T, Salazar N, Gutierrez-Diaz I, de Los Reyes-Gavilan CG, Gueimonde M, Gonzalez S. | Nutrients | 10.3390/nu9060551 | 2017 | ||
| Metabolism | Cytokine Response after Stimulation with Key Commensal Bacteria Differ in Post-Infectious Irritable Bowel Syndrome (PI-IBS) Patients Compared to Healthy Controls. | Sundin J, Rangel I, Repsilber D, Brummer RJ. | PLoS One | 10.1371/journal.pone.0134836 | 2015 | |
| Identification of herbal drug extracts that promote growth of Akkermansia muciniphila in high-fat diet fed mice. | Fujisaka S, Watanabe Y, Toume K, Morinaga Y, Nawaz A, Kado T, Nishimura A, Bilal M, Aslam MR, Igarashi Y, Nakagawa Y, Tobe K. | Diabetol Int | 10.1007/s13340-024-00713-w | 2024 | ||
| Metabolite-mediated interactions and direct contact between Fusobacterium varium and Faecalibacterium prausnitzii. | Hosomi K, Maruyama S, Matsuoka T, Furuta M, Tojima Y, Uchiyama K, Morita M, Kawashima H, Kobayashi T, Kunisawa J. | Microbiome | 10.1186/s40168-025-02168-w | 2025 | ||
| Metabolism | Akkermansia muciniphila and environmental enrichment reverse cognitive impairment associated with high-fat high-cholesterol consumption in rats. | Higarza SG, Arboleya S, Arias JL, Gueimonde M, Arias N | Gut Microbes | 10.1080/19490976.2021.1880240 | 2021 | |
| Preliminary Evaluation of the Safety and Probiotic Potential of Akkermansia muciniphila DSM 22959 in Comparison with Lactobacillus rhamnosus GG. | Cozzolino A, Vergalito F, Tremonte P, Iorizzo M, Lombardi SJ, Sorrentino E, Luongo D, Coppola R, Di Marco R, Succi M | Microorganisms | 10.3390/microorganisms8020189 | 2020 | ||
| Metabolism | Viability of microencapsulated Akkermansia muciniphila and Lactobacillus plantarum during freeze-drying, storage and in vitro simulated upper gastrointestinal tract passage. | Marcial-Coba MS, Cieplak T, Cahu TB, Blennow A, Knochel S, Nielsen DS | Food Funct | 10.1039/c8fo01331d | 2018 | |
| Spray-Drying Encapsulation of the Live Biotherapeutic Candidate Akkermansia muciniphila DSM 22959 to Survive Aerobic Storage. | Barbosa JC, Almeida D, Machado D, Sousa S, Freitas AC, Andrade JC, Gomes AM | Pharmaceuticals (Basel) | 10.3390/ph15050628 | 2022 | ||
| Pathogenicity | Characterization of antibiotic-resistance traits in Akkermansia muciniphila strains of human origin. | Filardi R, Gargari G, Mora D, Arioli S | Sci Rep | 10.1038/s41598-022-23980-6 | 2022 | |
| Phylogeny | Insights into the Antimicrobial Resistance Profile of a Next Generation Probiotic Akkermansia muciniphila DSM 22959. | Machado D, Barbosa JC, Almeida D, Andrade JC, Freitas AC, Gomes AM | Int J Environ Res Public Health | 10.3390/ijerph19159152 | 2022 | |
| Metabolism | Genome analysis and 2'-fucosyllactose utilization characteristics of a new Akkermansia muciniphila strain isolated from mice feces. | Gao W, Xiao M, Gu Z, Fu X, Ren X, Yu Y, Liu Z, Zhu C, Kong Q, Mou H | Mol Genet Genomics | 10.1007/s00438-022-01937-8 | 2022 | |
| Akkermansia beyond muciniphila - emergence of new species Akkermansia massiliensis sp. nov. | Kumar R, Hasselwander O, Kane H, Hibberd AA. | Microbiome Res Rep | 10.20517/mrr.2024.28 | 2024 | ||
| Reclassification of eight Akkermansia muciniphila strains and description of Akkermansia massiliensis sp. nov. and Candidatus Akkermansia timonensis, isolated from human feces. | Ndongo S, Armstrong N, Raoult D, Fournier PE. | Sci Rep | 10.1038/s41598-022-25873-0 | 2022 | ||
| Safety evaluation of Akkermansia massiliensis sp. nov. DSM 33459. | Pitt J, Bauter MR, Kumar R, Hasselwander O, Hibberd AA, Kane H, Wang Q, Auzanneau I, Bry S, David E, Seguinot P, Burns F, Smith AB. | Toxicol Rep | 10.1016/j.toxrep.2025.102042 | 2025 | ||
| Phylogeny | Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. | Derrien M, Vaughan EE, Plugge CM, de Vos WM | Int J Syst Evol Microbiol | 10.1099/ijs.0.02873-0 | 2004 |
| #16637 | Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH ; Curators of the DSMZ; DSM 22959 |
| #20215 | Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 ) |
| #40737 | ; Curators of the CIP; |
| #63059 | Culture Collection University of Gothenburg (CCUG) ; Curators of the CCUG; CCUG 64013 |
| #66792 | Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) . |
| #67770 | Japan Collection of Microorganism (JCM) ; Curators of the JCM; |
| #68380 | Automatically annotated from API rID32A . |
| #68382 | Automatically annotated from API zym . |
| #69479 | João F Matias Rodrigues, Janko Tackmann,Gregor Rot, Thomas SB Schmidt, Lukas Malfertheiner, Mihai Danaila,Marija Dmitrijeva, Daniela Gaio, Nicolas Näpflin and Christian von Mering. University of Zurich.: MicrobeAtlas 1.0 beta . |
| #121158 | Collection of Institut Pasteur ; Curators of the CIP; CIP 107961 |
| #124043 | Isabel Schober, Julia Koblitz: Data extracted from sequence databases, automatically matched based on designation and taxonomy . |
| #125438 | Julia Koblitz, Lorenz Christian Reimer, Rüdiger Pukall, Jörg Overmann: Predicting bacterial phenotypic traits through improved machine learning using high-quality, curated datasets. 2024 ( DOI 10.1101/2024.08.12.607695 ) |
| #125439 | Philipp Münch, René Mreches, Martin Binder, Hüseyin Anil Gündüz, Xiao-Yin To, Alice McHardy: deepG: Deep Learning for Genome Sequence Data. R package version 0.3.1 . |
| #126262 | A. Lissin, I. Schober, J. F. Witte, H. Lüken, A. Podstawka, J. Koblitz, B. Bunk, P. Dawyndt, P. Vandamme, P. de Vos, J. Overmann, L. C. Reimer: StrainInfo—the central database for linked microbial strain identifiers. ( DOI 10.1093/database/baaf059 ) |
You found an error in BacDive? Please tell us about it!
Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.
Successfully sent
If you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive17849.20260601.11
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data